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SUMMARY 
BACKGROUND: Improving embryo selection for embryo transfer is essential in 
Assisted Reproductive Technologies (ART), especially in single embryo transfer 
settings to reduce multiple birth rate. Current selection methods are largely based on 
assessment of morphological characteristics. Morphological blastocyst parameters 
have been shown in literature to correlate with implantation and live birth success 
rates, while female age is well established to affect overall assisted reproductive 
technology outcomes. More recently, kinetic parameters from time lapse (TL) 
technology have also emerged as additional selection characteristics during embryo 
development. As of yet, the effect of certain patient factors on kinetic parameters is to 
be elucidated. Syngamy is the merging event of maternal and paternal 
deoxyribonucleic acid (DNA) during fertilization and can be accurately determined / 
visualized using TL. The functional centrosome within the spermatozoa contributes to 
chromosome alignment and combination, therefore possibly impacting syngamy. The 
paternal genome from the spermatozoon also possibly contributes to blastulation on 
day 5 of embryo development by playing a role in the embryo genome activation, which 
drives advanced embryo development. The kinetic time points generated by TL 
technology during embryo development, can be used to examine the potential effect 
of male fertility diagnosis on syngamy and blastulation. This may elucidate whether 
syngamy timing is a relevant kinetic parameter that can allow more accurate selection 
and prediction of good quality embryos. 
AIMS: Primary aim: To investigate the possible measurable direct effect of male 
fertility prognosis using TL, on the time duration to the syngamy fertilization event. 
Secondary aim: To investigate the subsequent effect of male fertility prognosis using 
TL, on syngamy timing and the resulting advanced embryo development and 
blastocyst quality. 
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MATERIALS AND METHODS: This was a retrospective study that was conducted 
from 2017 to 2018 at Wijnland Fertility clinic on de-identified, aggregated TL patient 
embryo data from 2013 to 2016. Data was filtered according to inclusion and exclusion 
criteria and categorized according to defined male prognosis groups (good prognosis 
(GP), poor prognosis (PP), and very poor prognosis (VP)). Data was submitted for 
statistical analysis (statistical significance: P < 0.05). Female age was compensated 
for during statistical analysis. 
RESULTS: Results indicated that all three male prognosis groups (GP, PP, VP) had 
similar rates of normal fertilization (60.12%, 58.84%, and 54.29%, P = 0.19) and 
subsequent blastulation (64.75%, 69.61%, and 63.28%, P = 0.25). The GP group 
showed significantly shorter syngamy timing compared to the VP group (19.73 ± 3.69 
hours vs 20.80 ± 4.71 hours, P = 0.02). Shorter syngamy timing significantly correlated 
with increased blastocyst expansion on day 5 of embryo development in all groups (P 
< 0.01). A shorter syngamy timing significantly correlated with A-grade trophectoderm 
epithelium (TE) quality compared to B-grade (P = 0.02). A-grade TE in the GP group 
(P = 0.05) and VP group showed significantly shorter syngamy timing compared to B-
grade in the VP group (P =0.04). Syngamy timing did not show any significant 
correlation with inner cell mass (ICM) quality (P = 0.36) or between male prognosis 
groups (P = 0.13). 
CONCLUSION: Results indicated that although fertilization and blastulation rate 
amongst the male prognosis groups were similar, poorer male prognosis may lead to 
extended syngamy timing and poorer blastocysts, impacting expansion and 
trophectoderm epithelium quality specifically. Since these two blastocyst parameters 
are the most important indicators of embryo implantation potential, syngamy can 
therefore be an early predictive marker for blastocyst quality, irrespective of initial 
sperm prognosis. 
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OPSOMMING 
AGTERGROND: In die veld van reproduktiewe biologie en in vitro bevrugtingmetodes 
is enkel embrioterugplasing belangrik vir die vermindering van meervoudige 
geboortesyfers. Dit is dus essensiëel om embrioseleksie te optimeer. Huidige 
seleksiemetodes is grootliks gebasseer op morfologiese evaluering. Kinetiese 
parameters is onlangs ontwikkel, met behulp van tydsverloop-tegnologie (TL), wat 
addisionele embrioseleksie hulpmiddels bied. Die effek van spesifieke pasiëntfaktore 
op kinetiese parameters is tans nog eksperimenteel en nie ten volle ondersoek, bewys 
of beskryf nie. Vroulike ouderdom is wel reeds bewys as een van die hoof rolspelers 
in algehele reproduktiewe in vitro behandelingsuitkomste. Singamie is die 
samesmelting van vroulike en manlike deoksiribonukleïensuur (DNS) tydens die 
proses van bevrugting en kan duidelik gevisualiseer word met TL. Die funksionele 
sentrosoom binne die spermatosoön is verantwoordelik vir chromosoom belyning en 
samesmelting. Spermatosoa speel dus ‘n belangrike rol tydens die proses van 
singamie. Die manlike genoom, afkomstig van die spermatosoön, dra by tot 
blastosering op dag 5 van embrio-ontwikkeling en die aktivering van die 
embriogenoom gedurende gevorderde embrio-ontwikkeling. Kinetiese tydspunte 
gedurende embrio-ontwikkeling, met behulp van TL, kan gebruik word om die 
potensiële effek van manlike fertiliteitsdiagnose op singamie en blastosering te 
ondersoek. Bevindinge kan moontlik lei tot meer akkurate evaluering van 
embriokwaliteit en dus meer akkurate embrioseleksie vir embrioterugplasing.  
DOELWITTE: Primêre doelwit: Ondersoek die moontlike meetbare effek van manlike 
fertilliteitsprognose op die tydsverloop tot singamie, waartydens die spermatosoön 
noodsaaklike sentrosome voorsien.  
Sekondêre doelwit: Ondersoek die effek van manlike fertiliteitsprognose op die 
gevolglike gevorderde embrio-ontwikkeling, waartydens die manlike genoom ‘n 
aktiewe rol speel in blastosistontwikkeling en kwaliteit.  
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MATERIALE EN METODES: Hierdie was ‘n retrospektiewe studie vanaf 2017 tot 
2018 by Wijnland Fertiliteitskliniek op ‘n onïdentifiseerbare, saamgevoegde TL 
databasis van in vitro bevrugtingsgevalle se embrio-ontwikkeling op data vanaf 2013 
tot 2016. Data was volgens die insluit- en uitsluitingskriteria gefiltreer en 
gekategoriseer volgens bepaalde manlike prognosegroepe (goeie prognose (GP); 
swak prognose (PP); baie swak prognose (VP)). Die data was daarna ingehandig vir 
statistiese analise (statistiese beduidenheid: P < 0.05). Die moontlike verwagte effek 
van vroulike ouderdom was in berekening gebring tydens statistiese ontleding. 
RESULTATE: Resultate dui aan dat al drie manlike prognosegroepe (GP, PP, VP) 
soortgelyke normale bevrugting- (60.12%, 58.84%, en 54.29%, P = 0.19) en 
blastoseringwaardes getoon het (64.75%, 69.61%, en 63.28%, P = 0.25). Die GP 
groep het ‘n korter singamie tyd getoon in vergelyking met die VP groep (19.73 ± 3.69 
ure teenoor 20.80 ± 4.71 ure, P = 0.02). Korter tydsverloop tot singamie in alle groepe 
het beduidend gekorreleer met verder gevorderde blastosistvergroting op dag 5 van 
embrio-ontwikkeling (P < 0.01). Korter tydsverloop tot singamie het ook gekorreleer 
met trofektoderm kwaliteitsgradering, spesifiek tussen A- en B-graad trofektoderm (P 
= 0.02). Tydsverloop tot singamie was beduidend korter vir A-graad trofektoderm in 
die GP groep (P = 0.05) en VP groep in vergelyking met B-graad trofektoderm in die 
VP (P = 0.04). Tydsverloop tot singamie het geen beduidende korrelasie getoon met 
binneselmassa kwaliteit oorhoofs (P = 0.36), asook nie tussen die manlike 
prognosegroepe (P = 0.13) nie. 
GEVOLGTREKKING: Resultate dui daarop dat alhoewel bevrugting- en 
blastoseringwaardes van die manlike prognosegroepe soortgelyk was, het swakker 
manlike prognose gelei tot verlengde tydsverloop tot singamie en gevolglik ook tot 
swakker blastosist kwaliteit. Die effek van verlengde singamie was veral op blastosist 
vergroting en trofektoderm kwaliteit waargeneem. Aangesien singamie spesifiek met 
hierdie twee belangrike blastosist parameters korreleer, wat goeie indikators van 
implantasie potensiaal is, kan singamie moontlik ’n vroeë indikator wees van blastosist 
kwaliteit, ongeag die sperm prognose. 
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ABBREVIATION LIST 
General Assisted Reproductive Technology terms 
ANOVA Analysis of variance. 
ART Assisted Reproductive Techniques. 
BQ Blastocyst Quality. 
CM Compact Morula. 
CPR Clinical pregnancy rate. 
DC Distal centriole. 
DFI Deoxyribonucleic acid fraction index. 
EB Early Blastocyst. 
EGA Embryo genome activation. 
GEE Generalized estimating equations. 
GP Good prognosis. 
GV Germinal Vesicle (Immature Oocyte). 
HA Hyaluronic acid. 
HDS Highly deoxyribonucleic acid stainable. 
ICM Inner Cell Mass. 
ICSI Intracytoplasmic sperm injection. 
IMSI Intra cytoplasmic morphologically selected sperm injection. 
IR Implantation rate. 
IUI Intra-uterine insemination. 
IVF In vitro Fertilization. 
LBR Live birth rate. 
LSD Least significant difference. 
MII Metaphase II (Mature Oocyte). 
MI Metaphase I (Immature Oocyte). 
OR Ongoing pregnancy rate. 
PB Polar Body. 
PC Proximal centriole. 
PCM Pericentriolar material. 
PCOS/PCO Polycystic ovarian syndrome / Polycystic ovaries. 
PGT-A Preimplantation genetic testing for aneuploidies. 
PGT Preimplantation genetic testing. 
PICSI Physiological intracytoplasmic sperm injection. 
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PN 
Pronuclei (2PN = normal fertilization, 0,1,3,>4 PN = abnormal 
fertilization). 
PP Poor prognosis. 
PVS Perivitelline space. 
RNA Ribonucleic acid. 
SET Single Embryo Transfer. 
SCSA Sperm chromatin structure assay. 
SOP Standard Operating Procedures. 
TE Trophectoderm Epithelium. 
TL Time-Lapse. 
TUNEL 
Terminal deoxynucleotidyl transferase-mediated deoxy-uridine 
triphosphate nick end labelling. 
VP Very poor prognosis. 
ZP Zona Pellucida. 
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Embryo developmental time-points 
t0 Time of insemination. 
tPB2 Time to second polar body extrusion. 
tPNa Time to pronuclear appearance. 
tPNf Time of pronuclear fading. 
t2 -t8 Time of cleavages at specific cell stages (t2 = time to 2 cell division, 
t8 – time to 8 cell division). 
tM Time to morulation. 
tSB Time to start of blastulation. 
tB Time to full blastocyst. 
tEB Time to expanding blastocyst. 
tHB Time to hatching blastocyst. 
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Genetic terms 
DNA Deoxyribonucleic acid. 
G1 
Stage of interphase in the cell cycle in which the cell grows and 
develops. 
G0 Non-dividing phase of the cell cycle (gap 0). 
S-phase Stage of interphase in the cell cycle where DNA replicates. 
G2 
Stage of interphase in the cell cycle that follows DNA replication. The 
cell prepares for division. 
Meiosis I 
First phase of meiosis. In meiosis I, chromosome number is reduced 
by half. 
Meiosis II 
Second phase of meiosis. Events in meiosis II are essentially the 
same as those in mitosis. 
M-phase Process by which the nucleus of a eukaryotic cell divides/cleaves. 
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INTRODUCTION 
Time-lapse (TL) technology emerged in the 1990’s, with the first observations of 
fertilization in oocytes by Payne et al. (1997). 
Multiple pregnancy outcomes are a concerning part of Assisted Reproductive 
Technology (ARTs) and single embryo transfer (SET) strategies are becoming the 
more preferred option to reduce resultant obstetric risks and poor neonatal outcomes. 
This necessitates the development of better embryo selection methods. 
TL incubators allow embryologists to access kinetic data from embryo development, 
which could assist in improving selection methods. Embryo selection is usually based 
on embryo and/or blastocyst morphology. Many studies have been done using TL 
technology with the goal to improve embryo selection and predict assisted 
reproductive technology (ART) outcomes (Meseguer et al., 2011, Basile et al., 2014a, 
Basile et al., 2014b, Rubio et al., 2014, Wirka et al., 2014, Goodman et al., 2016, Chen 
et al., 2017, Aparicio Ruiz et al., 2018). 
Syngamy is the merging of maternal and paternal deoxyribonucleic acid (DNA), which 
is one of the early fertilization events that can be annotated clearly and accurately. 
This time point has been included in many studies investigating ART outcomes, but 
not yet to investigate the effect of male fertility prognosis (Azzarello et al., 2012, Ueda 
et al., 2012, Aguilar et al., 2014, Wirka et al., 2014).  
Male factor prognosis is categorized according to male diagnosis that is determined 
through standard semen analysis. The functional centrosome within the spermatozoa 
contributes to DNA alignment and combination, therefore possibly impacting syngamy. 
The paternal genome from the spermatozoon also plays a role in blastulation by 
contributing to the embryo genome, which drives advanced embryo development. 
However, syngamy timing and its interaction with male prognosis and subsequent 
blastocyst quality has not been investigated. Early embryo developmental events, 
such as syngamy could allow earlier prediction of blastocyst quality. 
The main focus of this study is to investigate the effect of male fertility prognosis on 
syngamy timing and blastocyst quality by making use of time-lapse technology, which 
will be substantiated in the literature review. 
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In Chapter 1 background information as mentioned above is reviewed and compiled 
as a Literature Review. 
In Part 1 of the Literature Review an overview and introduction of ART is given. 
In Part 2 the main technology used in this study, TL systems, is discussed. 
In Part 3 the determination of male factor prognosis is described and discussed. 
In Part 4 the process of oogenesis is broadly discussed, as well as female factors 
affecting fertility. 
In Part 5 the activation of the oocyte and the fertilization process are discussed. 
In Part 6 the formation of pronuclei is discussed, as well as the recent relevance of 
pronuclear morphology during evaluation. 
In Part 7 the role of the spermatozoa in syngamy and the embryo genome is 
elaborated on. 
In Part 8 embryo blastulation and grading on day 5 of culturing are discussed. 
In Part 9 the Literature Review is concluded and final remarks are stated. 
In the remainder of Chapter 1, the research question, hypothesis, aims and objectives 
are stated. 
In Chapter 2 the Materials and Methods are detailed, which include: 
Part 1 -  The Study design, Part 2 - Study population, Part 3 - Exclusion criteria, Part 
4 - Sample size, Part 5 - Division into male prognosis groups, Part 6 – Data 
Management, Part 7 - ART methods used, Part 8 -Semen analysis and diagnosis 
determination, Part 9 – Time-lapse incubation equipment, Part 9.1 - Equipment details 
of the EmbryoScopeTM incubator, Part 9.2 - Time-lapse embryo culture dish 
preparations Part 10 - Embryo annotation and syngamy determination, Part 11 - 
Embryo blastocyst evaluation, Part 12 – Flow diagram of the data management, Part 
13 – Limitations of the study, Part 14 -Ethical considerations and Part 15 - Statistical 
analysis.  
In Chapter 3 the Results of the study are presented.  
In Chapter 4 the results are reviewed in the Discussion section. 
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In Chapter 5 the Conclusion of the findings of the study is formulated. 
In Chapter 6 the Future prospects are discussed. 
In Chapter 7 the cited References throughout the thesis are alphabetically listed. 
In Chapter 8 the Appendices A-G is included. 
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CHAPTER 1  
LITERATURE REVIEW 
 Overview of Assisted Reproductive Technologies (ART) 
ART (Assisted Reproductive Technologies) have been developed to overcome certain 
infertility diagnoses, with the first human birth resulting from in vitro fertilization (IVF) 
treatment, dating back to 1978. IVF has been successful for the treatment of couples 
with female factor infertility, which include tubal disease, endometriosis and 
unexplained infertility (Devroey and Van Steirteghem, 2004). Palermo et al. (1992) 
published on the first pregnancies and deliveries that resulted from intracytoplasmic 
sperm injection (ICSI). ICSI was specifically intended to treat male factor infertility and 
is currently the technique of choice for in vitro treatment worldwide to improve 
fertilization and pregnancy success. This procedure entails the selection of one 
spermatozoon based on morphological appearance, to be injected into one oocyte by 
means of micromanipulation needles fitted to an inverted microscope.  
IVF is usually indicated as treatment for patients who have a good male prognosis and 
normal diagnosis. IVF entails insemination of oocytes by adding processed 
spermatozoa to oocytes and allowing spermatozoa to penetrate and fertilize the 
oocyte in a more natural selecting in vitro fashion, which resembles in vivo 
circumstances as close as possible.  
A study done by Plachot et al. (2002) evaluated these two insemination methods, 
conventional IVF and ICSI, in patients with either one or a combination of male factor 
infertility which included: moderate oligozoospermia, asthenozoospermia and/or 
teratozoospermia, as well as obstructive and non-obstructive azoospermia. Overall 
results showed no significant difference between ICSI and IVF in fertilization rate, 
embryo morphology or developmental, pregnancy and implantation rates. 
Yoeli et al. (2008) conducted a study on sibling oocytes inseminated by IVF and ICSI 
methods to determine whether there is a difference in embryo quality. They found 
higher fertilization rates in ICSI than in IVF (67.1% vs 43.6%), but found no significant 
difference in the embryo quality. They postulated that embryo quality did not depend 
on insemination method, but rather on inherent gamete factors. 
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A meta-analysis done by Johnson et al. (2013) showed that ICSI compared to 
conventional IVF gave better fertilization rates and decreased risk of total fertilization 
failure in couples with unexplained infertility. 
Embryo quality is an important factor for its successful implantation into the 
endometrium (Oron et al., 2014). It is dependent on the physiological function of both 
male and female gametes to complete important developmental milestones during 
embryo development. 
In the effort to improve ICSI outcomes, two variations thereof have been developed in 
ART treatment, namely physiological intra-cytoplasmic sperm injection (PICSI) and 
intra cytoplasmic morphologically selected sperm injection (IMSI). These variations 
aim to improve sperm selection based on maturity or morphology and consequent ART 
outcomes in patients who have either had failed or poor ICSI cycle outcomes. Poor 
outcomes may be due to fertilization failure, failed blastocyst formation, low-quality 
blastocyst yield or chromosomal aberrations (Mokánszki et al., 2014, Luna et al., 2015, 
Gatimel et al., 2016, Orief et al., 2016, Erberelli et al., 2017).  
PICSI is based on the principle of hyaluronic acid (HA) binding. HA is present around 
the oocyte as part of the cumulus oocyte complex (COC), which acts as a selector for 
mature spermatozoa, which have HA-receptors, to bind to the oocyte (Beck-Fruchter 
et al., 2016). Spermatozoa that bind to HA, are possibly more mature with less DNA 
fragmentation and fewer chromosomal mutations. However, literature shows 
contradicting evidence to whether PICSI is advantageous in comparison to the 
conventional ICSI (Beck-Fruchter et al., 2016, Erberelli et al., 2017). 
IMSI is based on high magnification (>6000 times) in order to better identify and select 
morphologically normal spermatozoa, which correlate with decreased DNA 
fragmentation (Orief et al., 2016). However, literature also shows contradicting 
evidence regarding the improvement in ART outcomes when implementing IMSI in 
comparison to traditional ICSI (Luna et al., 2015, Gatimel et al., 2016, Orief et al., 
2016). 
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In further effort to maximize the chance of implantation, the transfer of multiple 
embryos, mostly 2 to 3 embryos, have been common practice. This has also led to 
high multiple pregnancy rates with increased risk for perinatal complications, which 
include low birth weight and premature delivery, as well as risks for the mother 
(Papageorghiou et al., 2006, Vega et al., 2016). It has been shown that there is an 
increase in morbidity and mortality from preterm births, which increase with multifetal 
pregnancies (Haas et al., 2016). In order to reduce multiple pregnancies and the 
obstetric risks that are associated with them, more laboratories are favouring single 
embryo transfers (SET) (Ahlström et al., 2011). Therefore, embryo selection has 
become a crucial task in IVF laboratory practice to identify the embryo most likely to 
result in a live birth.  
 Time-lapse (TL) technology for human embryo culture 
Traditional embryo culturing and incubation are conducted in benchtop incubators, 
which allow embryologists to view and evaluate embryos daily at only one static time 
point. Embryos need to be removed from the incubator for evaluation, causing 
disruption of embryo culture conditions, which could distress the embryo if exposed to 
the external environment for too long (Kovacs, 2014). 
TL imaging for the study of early embryonic development started in the 1990’s 
(Campbell and Fishel, 2015). Payne et al. (1997) revolutionized the first time-lapse 
observations in human oocytes by recording the first steps in the process of 
fertilization. The recent emergence of commercial TL incubation technology has 
developed into a new era of morphokinetic information where standard embryo 
culturing, incubation and monitoring for evaluation can be achieved without disturbing 
culture conditions (Kovacs, 2014). TL incubators are installed with microscope-based 
cameras that are able to photograph embryos every few minutes and in combination 
with computer software, can create a video of every embryo’s development. In some 
TL systems, additional embryo tracking software is included. 
There are several patented TL systems available: the EmbryoScopeTM (FertiliTech, 
Denmark), the Primo Vision (Vitrolife, Sweden), the Eeva (Early Embryo Viability 
Assessment) (Auxogyn, United States), and the Miri (Esco, Denmark). 
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The EmbryoScopeTM (FertilitTech, Denmark) is a non-humidified incubator with a built-
in TL system and EmbryoViewer software to allow annotation of embryos. The camera 
system uses low intensity red (LED 635nm) illumination, able to visualize the embryo 
in 7 focal to 9 equidistal planes (Kovacs, 2014, Campbell and Fishel, 2015). This 
incubator can hold 6 EmbryoSlide® dishes, which can accommodate up to 12 embryos 
per slide per patient. The system can track up to 72 embryos in total from 6 patients. 
Imaging is performed by automatically moving the dish by means of a motorized 
holding tray to bring the embryos into camera view. 
The Primo Vision (Vitrolife, Sweden) is a portable TL unit that is placed in a 
conventional incubator and connected to an external controlling device (Kovacs, 2014, 
Campbell and Fishel, 2015). This system uses a compact, inverted microscope with 
Hoffman contrast integrated optics and green (LED 550nm) illumination that is able to 
visualize the embryo in 11 focal planes. Dishes for this TL system can accommodate 
9 or 16 embryos per patient, allowing group culture as well as individual embryo 
monitoring. One Primo Vision unit is required for each patient, and a complete system 
of six units can track up to 96 embryos from six patients. Imaging is performed 
statically, without moving the dish, therefore minimizing disturbances.  
The Eeva (Early Embryo Viability Assessment) (Auxogyn, United States) system is 
also a TL unit that is placed in a conventional incubator. The imaging system uses a 
dark-field illumination in order to increase cell membrane definition and visualizes 
embryos in a single focal plane (Kovacs, 2014, Campbell and Fishel, 2015). The 
Auxogyn software allows the Eeva system to predict every embryo’s potential of 
developing to blastocyst stage, by tracking blastomere cleavages and using evaluation 
markers in the first two days post-fertilization. The Eeva dish includes individual wells 
for up to 9 embryos and also allows group-culturing. 
The Miri® TL (Esco, Denmark) system is an incubator with 6 separate chambers that 
can accommodate 14 embryos per CultureCoins dish and 84 embryos in total 
(Campbell and Fishel, 2015). The imagining system uses red LED illumination and 
has a built-in high definition (HD) resolution interface touchscreen. This systems’ 
software has an assist function which automatically detects the first cleavages to 
compare actual timings to reference timings for easier embryo selection. 
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The choice of TL incubation system is usually based on each laboratory’s 
requirements, budget and available space.  
It is clear that TL imaging systems allow the embryologist to observe embryo 
development in greater detail with better insight into timing of events such as 
pronuclear formation, syngamy, cleavage events, cell cycle events, synchronicity of 
cell division and blastulation. TL allows laboratories to conduct continuous monitoring 
of the embryo’s development and ensures that timing of embryo development events 
can be determined more accurately (Desai et al., 2014). The images and data can be 
recalled at any stage, can be re-evaluated if needed and be exported for research 
purposes. Many studies have been conducted using TL systems to improve embryo 
selection and interesting results have been published (Rubio et al., 2014, Goodman 
et al., 2016, Chen et al., 2017, Aparicio Ruiz et al., 2018).  
Goodman et al. (2016) conducted a prospective, randomized control study to 
determine whether morphokinetic data from the TL EmbryoScopeTM system improved 
clinical pregnancy rate (CPR) and implantation rates (IR) compared to traditional 
dynamic evaluation. The study showed no improvement in CPR, but did show 
improvement in IR for embryos with better morphokinetic data. Aparicio Ruiz et al. 
(2018) completed a retrospective study to investigate the difference of embryo quality 
and euploidy rate in two TL incubator systems compared to a traditional benchtop 
incubator. Their results showed an increased good quality embryo rate in both TL 
systems compared to the benchtop incubator. One of the TL systems showed 
increased euploidy rates in comparison with another TL system, as well as compared 
to the conventional incubator. 
Rubio et al. (2014) conducted a prospective, double blind and randomized control 
study to assess the reproductive outcomes between the EmbryoScopeTM TL system, 
with its additional morphokinetic information and traditional incubators, based only on 
morphology. The main outcomes included IR, pregnancy, ongoing pregnancy rates 
(OR) and early pregnancy loss. Results showed that the EmbryoScopeTM TL system 
had improved reproductive outcomes in comparison to standard embryo benchtop 
incubators. 
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A meta-analysis and systematic review of randomized controlled trials by Chen et al. 
(2017) showed there is not enough substantial evidence that TL is more effective or 
superior than conventional benchtop embryo incubation, but it is definitive that TL 
provides a large amount of data which provides an enhanced tool for research in the 
field of embryology that could lead to better embryo selection. 
Key events that take place during embryo development can offer prediction of 
blastocyst development and assist in deselection of embryos with low probability of 
viability (Mölder et al., 2015). Desai et al. (2014) conducted a study looking at time to 
syngamy, time to two cells, thee, four, five and eight cells, morula, start of blastulation 
and time to full blastulation by using an EmbryoScopeTM TL incubator. They found that 
the data generated from this embryo selection method can potentially enhance embryo 
selection and improve transfer outcomes. Wirka et al. (2014) did a study using time-
lapse microscopy to identify atypical embryo phenotypes by looking at abnormal 
syngamy, abnormal first cytokinesis, abnormal cleavage and chaotic cleavage. They 
concluded that atypical phenotypes correlate to lower developmental potential of 
embryos compared to their control embryos (Wirka et al., 2014). 
Time lapse incubation of embryos from fertilization to blastocyst stage can thus 
generate morphokinetic data in a non-invasive setting of specific developmental 
events of every embryo, such as syngamy and blastulation. This provides valuable 
analysable information about embryo development to help improve embryo selection. 
Algorithms based on TL morphokinetic data have previously been proposed to 
improve embryo selection (Herrero and Meseguer, 2013). 
A study by Wong et al. (2010) pioneered an algorithm based on time-lapse 
morphokinetic markers and associated gene expression profiles. They compiled a 
timeline from which they derived the algorithm to predict blastocyst formation in very 
early stages of embryo development, before the embryo genome activation (EGA). 
The findings reveal that the maternal messenger ribonucleic acids (mRNA’s), 
originating from the oocyte, plays a role in the cleavage stages before EGA, but 
fertilization and spermatozoa factors have not been elucidated yet (Wong et al., 2010). 
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In another study by Meseguer et al. (2011) in which they retrospectively analysed the 
morphokinetic embryo developmental parameters of 2903 oocytes and correlated this 
information with implantation. Results showed that non-implanting embryos had 
increased variance of morphokinetic parameters compared to implanting embryos. 
Their hierarchical tree which was formulated to compare morphology classes, showed 
that TL classification was more accurate. TL could therefore contribute to embryo 
selection and subsequently improve clinical outcomes in ART. 
Basile et al. (2014a) studied the time between cleavages of euploid and aneuploid 
embryos, using the EmbryoScopeTM TL system, to contribute to algorithms to improve 
non-invasive selection of euploid embryos. Results showed that euploid embryos had 
different kinetic behaviour compared to aneuploid embryos, on which they based their 
proposed algorithm to aid in classification of probable euploid embryos.  
Basile et al. (2014b) did a large multicentred retrospective study on morphokinetic 
markers and its ability to predict implantation potential of an embryo by developing an 
algorithm that can be applied in different IVF clinics. The results showed that 
morphokinetic data with regards to timing of cleavages to 3-cell and 5-cell, as well as 
timing of the second cell cycle correlated with implantation in clinics that used similar 
methods. The continuous development and improvement of such algorithms could 
assist in selecting better embryos with higher implantation potential. 
Fishel et al. (2018) conducted a retrospective study to measure live birth outcome by 
ranking blastocysts according to morphokinetic-based algorithms. Their main time 
point evaluated was time to start of blastulation (tSB) until time of full blastulation (tB) 
and embryos were ranked from A to D. They used time to pronuclei fading (tPNf) as 
the reference time point (t0), where they found that IVF embryos had a longer tPNf of 
1.95 hours post insemination compared to ICSI. The main conclusion was that TL 
morphokinetic based algorithms can rank embryos according to prediction of live birth, 
with greater discrimination abilities than traditional embryo morphology grading. 
TL morphokinetic data could therefore be used to specifically investigate the impact 
that male spermatozoa diagnosis has on syngamy timing and advanced embryo 
development i.e. blastulation. Accurate syngamy timing, its correlation with male 
diagnosis and blastulation have not been studied and could contribute to future 
algorithm development. 
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 Male factor prognosis  
Male factor prognosis is determined through a standard semen analysis. Semen 
analysis outcomes are based on semen parameters, such as spermatozoa 
concentration, motility, and morphology. Multiple studies have shown that these 
parameters have a positive correlation with in vitro fertilization success and pregnancy 
(Coetzee et al., 1998). Approximately 50% of IVF treatments are done because of 
male factor infertility (Nanassy and Carrell, 2008). 
Semen analysis investigates parameters that determine the male factor prognosis. 
The World Health Organization (WHO, 2010) has set standard reference values for 
semen parameters and male diagnosis. Descriptions of each diagnosis can be found 
in Appendix A.  
Semen parameters are determined by following protocols set out by the WHO manual, 
although different laboratories may follow modified references determined within their 
clinical setting. Spermatozoa concentration or count can be assessed by making use 
of a Neubauer haemocytometer, which is a counting chamber with gridlines that is 
covered by a special coverslip (WHO, 2010). The semen is diluted with sterile water 
and loaded onto the counting chamber, where spermatozoa are counted and a 
concentration is determined. The motility of the sample is determined on a wet 
preparation slide, which is a slide on which a drop of semen is placed and is covered 
with a coverslip to provide a chamber of approximately 20μm in depth (WHO, 2010). 
The percentage of motile spermatozoa is then estimated across different fields, of 
which at least 10 fields are examined.  
Spermatozoa morphology is an important part of a semen analysis, which allows 
selection of spermatozoa that have the best potential to fertilize the oocyte (WHO, 
2010). This is based on the findings of Menkveld and colleagues (Menkveld et al., 
1990), as well as other scientists, where normal spermatozoa classification was 
described from spermatozoa recovered from cervical mucus in the female 
reproductive tract and bound to the zona pellucida of the oocyte (WHO, 2010). Sperm 
morphology evaluation is performed by making smears of the semen sample and 
staining these in order to assess morphology, which should be based on 100 to 200 
spermatozoa (Acosta and Kruger, 1996, Björndahl et al., 2010, WHO, 2010). The 
percentage indicates the number of spermatozoa with a normal form. 
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Spermatozoa are classified into three different morphology categories, 1-4% (P-
pattern), 5-14% (G-pattern) and >15% (N-pattern) (Björndahl et al., 2010). 
Spermatozoa are graded by looking at multiple morphological factors: (1) head shape, 
(2) neck / midpiece, and the (3) principal and end piece, which is the tail (WHO, 2010). 
Borderline cases are assessed as abnormal (Acosta and Kruger, 1996, WHO, 2010). 
The head is assessed according to its size, form and structure (Björndahl et al., 2010, 
WHO, 2010). The size of the head should not be too large or too small, have an oval 
form, an acrosome of more than 30% and less than 60% of the head size, no head 
abnormalizes or duplications of structures (Björndahl et al., 2010, WHO, 2010). The 
neck cannot be too thick or thin, cannot be bent and asymmetrical insertions of the tail 
is regarded as abnormal (Björndahl et al., 2010, WHO, 2010). The tail should not be 
bent or coiled, duplicated, too short, or irregularly thick (Björndahl et al., 2010, WHO, 
2010). Cytoplasmic residues are an indication of spermatozoon immaturity and is 
considered abnormal (Björndahl et al., 2010, WHO, 2010).  
Since ICSI has been developed for treatment of poor male prognosis, spermatozoa 
with poor parameters (concentration, motility and morphology) can be used for 
fertilization, although poor prognosis in male factor infertility has shown to compromise 
clinical pregnancy outcomes after ART (Coetzee et al., 1998). This is probably due to 
the fact that ICSI selects for the best possible sperm based on motility and 
morphology, but it does not necessarily select normal genetic and epigenetic 
spermatozoa profiles (Denomme et al., 2018). Compromised genetics inherited from 
the spermatozoa most probably contribute to impaired embryo development after 
fertilization.  
It has been shown that immotile or non-progressive spermatozoa have increased 
centriole abnormalities compared to motile spermatozoa (Sathananthan, 1994, 
Palermo et al., 1997). Syngamy prevention in reversed vasectomized patients could 
be due to antibody formation against centrioles, and timing of pronuclei (PN) 
positioning could be affected when using compromised spermatozoa (Palermo et al., 
1997). Thus, poor male prognosis may affect the fertilization events. 
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In the literature, there is no consensus about the effect of male diagnosis and semen 
parameters on ART fertilization rate. Hourvitz et al. (1998) found a significantly lower 
fertilization rate of testicular retrieved spermatozoa, obtained from patients with either 
non-obstructive azoospermia or oligo-astheno-teratozoospermia (42%), compared to 
the control group of ejaculated spermatozoa (55.5%). Zheng et al. (2016) conducted 
a retrospective cohort study and found that patients with reduced motility in addition 
to severe oligozoospermia had a significantly decreased fertilization rate in 
comparison to only moderate oligozoospermia patients, as well as decreased rate of 
good quality day 3 embryos in comparison to the control group. 
Verza Jr and Esteves (2008) found that patients with triple sperm defect diagnoses 
and patients with testicular spermatozoa from non-obstructive azoospermia diagnoses 
had lower fertilization rates in comparison to other spermatozoa diagnoses (63.4 ± 
25.9%; 52.2% ± 29.3% and ~73% respectively). 
Borges Jr et al. (2017) conducted a study to evaluate the effect of male factor infertility 
on ICSI outcomes in comparison to a tubal factor control group according to maternal 
ages. Their results showed that normal fertilization rates did not differ significantly 
between male factor (81.33 ± 19.92%) and tubal factor groups (84.31 ± 15.99%) in 
women older than 35 years of age. The only significant result was in cycle cancelation 
rate, which was higher in male factor patients. However, there were significant 
differences in women under 35 years of age, who had a higher fertilization rate in the 
tubal factor group (86.43 ± 14.08%) compared to the male factor group (82.66 ± 
17.32%). They also reported a higher number of transferred embryos in the male factor 
group, but no differences were seen in the implantation rate and pregnancy rate 
between the groups. Their overall fertilization rate between the male factor group 
(82.28 ± 18.09%) and the tubal patency group (85.64 ± 14.81%) was also significantly 
different when female age groups were not taken into consideration. The blastulation 
rates (42.10± 26.64% vs 43.00 ± 29.0%) and embryo quality was not affected by male 
factor. Their final conclusion was that male factor infertility does not interfere with the 
success of ICSI and that ICSI overcomes the poor specific outcomes associated with 
male factor. 
 
Stellenbosch University  https://scholar.sun.ac.za
20 
 
In contrast, results by Yerebasmaz et al. (2017) showed that patients receiving ICSI 
treatment due to male factor infertility and tubal-unexplained infertility had no 
significant difference in fertilization (50.8% vs 51.2%, respectively), implantation 
(35.1% vs 37.0%, respectively) or clinical pregnancy (26.2% vs 30.8%, respectively) 
rates. However, after investigating the method of acquiring the spermatozoa, either by 
surgical extraction or ejaculation, ejaculated spermatozoa had an increase in 
fertilization rate (43.5% vs 51.8%, respectively), although not statistically significant.  
Bungum et al. (2004) aimed to determine the relationship between the status of the 
sperm chromatin structure assay (SCSA) and the outcomes of biochemical pregnancy, 
clinical pregnancy and delivery in IVF, ICSI and intrauterine insemination (IUI). SCSA 
results were measured as DNA fractionation index (DFI) and highly DNA stainable 
(HDS) cell fractions. Their results showed that the group with less than 27% DFI and 
less than 10% HDS had a significantly better chance of successful pregnancy and 
delivery. Results also showed that in patients with more than 27% DFI, ICSI had 
significantly better outcomes in comparison to IVF. They concluded that SCSA could 
predict the outcome of ART. 
Weissman et al. (2008) did a case series of four couples with male factor infertility and 
failed IVF or ICSI cycles. These ICSI cycles used ejaculated spermatozoa, which 
resulted in poor embryo quality and repeated implantation failure. Standard practice 
only resorts to testicular retrieval of spermatozoa in azoospermic patients, but this 
study retrieved spermatozoa from the testis even though patients had motile 
spermatozoa in the ejaculate. In all four cases, the couples had positive implantation 
and ongoing pregnancy or delivery results. This might have been a small study, but 
suggests that testicular spermatozoa could be an alternative option for repeated 
IVF/ICSI failures. They speculated that these failures were due to spermatozoa DNA 
damage in the male reproductive tract.  
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Moskovtsev et al. (2010) compared DNA fragmentation of patients with failed oral 
antioxidant treatment in ejaculated spermatozoa to testicular spermatozoa. They 
performed terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate 
nick end labelling (TUNEL) assays. The results showed that ejaculated spermatozoa 
had three times more DNA fragmentation (39.7 ± 14.8%) in comparison to testicular 
spermatozoa (13.3 ± 7.3%). The obvious conclusion was that patients who had failed 
oral antioxidant treatment, showed improved DNA quality from testicular retrieved 
samples in comparison to ejaculated samples. 
Esteves et al. (2015) evaluated the ability of ICSI to overcome high sperm DNA 
fragmentation in male factor infertility. Male patients with oligozoospermia, as well as 
high DNA fragmentation, who had ICSI cycles using either ejaculated sperm samples 
or testicular sperm samples from surgical extraction or aspiration were included. They 
showed that testicular sperm had significantly lower DFI (8.3%) compared to 
ejaculated sperm (40.7%). The CPR between the testicular retrieved and ejaculated 
spermatozoa also differed with regards to CPR (51.9% vs 40.2%, respectively) and 
significantly differed in miscarriage rate (10.0% vs 34.3%, respectively) and live-birth 
rate (46.7% vs 26.4%, respectively). They concluded that testicular retrieval of 
spermatozoa in patients with oligozoospermia and high DNA fragmentation is an 
effective treatment option to improve ART outcomes. 
In the field of ART, there is a wide variety of patients with different spermatozoa 
diagnoses. The possible effect which it could have on syngamy timing and blastulation 
rate is unknown. The few studies mentioned, suggest that there might be an influence 
of male patient diagnosis, which we will be investigating. 
According to these studies, the quality of the spermatozoa affected fertilization and 
subsequent embryo potential and development. Therefore, the effects on early 
fertilization events, like syngamy timing and late embryonic development, such as 
blastulation is still unclear. 
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 Oogenesis and female factors 
Oogenesis is the process that produces female gametes. The ovaries are the site of 
oocyte production, where diploid primordial germ cells divide via mitosis to form 
oogonia. In the human female, oocytes form during fetal life, where each oogonium 
completes meiosis I, divides and arrests in meiosis at the prophase I stage, known as 
primary oocytes (Pierce, 2012, Coward and Wells, 2013). When puberty is reached, 
hormone levels stimulate the primary oocytes to complete meiosis I, where the oocyte 
proceeds to complete crossing over in prophase I, which allows intrachromosomal 
recombination to create new alleles on the chromatids (Pierce, 2012). Thereafter, 
metaphase I, anaphase I, telophase I and cytokinesis are completed (see Figure 1.1). 
The secondary oocyte and first polar body is formed and is distinguished by the 
proportion of cytoplasm allocated to each oocyte (Pierce, 2012). The first polar body 
extrusion characterizes a mature oocyte, it receives a small part of the cytoplasm and 
usually disintegrates. The secondary oocyte receives most of the cytoplasm, which is 
ovulated from the ovary and ready to be fertilized (Pierce, 2012, Campbell and Fishel, 
2015). The second division, meiosis II, is delayed until contact with the spermatozoa, 
after the secondary oocyte is penetrated and the oocyte is activated (Pierce, 2012). 
 
 
Figure 1.1 Diagram of the first meiotic phase.  
Image by: Ali Zifan - Own work; Used information from Campbell Biology (10th Edition) by: Jane B. 
Reece & Steven A. Wasserman, CCBY-SA4.0, 
https://commons.wikimedia.org/w/index.php?curid=49630204. 
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At birth, a female has approximately 1-2 million oocytes, which continuously declines 
as she approaches puberty (Liu et al., 2011). At puberty only 300 000- 500 000 million 
oocytes remain and during the reproductive years women will ovulate 400-500 
oocytes, with the remainder of the oocytes being lost through apoptosis (Liu et al., 
2011). 
Female age is a confounding factor in reproduction, which also plays a role in the 
prognosis of ART. As women age, their fertility declines when oocyte quantity, the 
quality of the DNA and biological function decreases. Age is therefore a good predictor 
of ovarian reserve. It is clear that embryo aneuploidy increases and success rates in 
ART decrease with advancing female age (Lawler et al., 2007, Liu et al., 2011). 
Studies conducted in Canada and in the United States showed that success in ART 
treatment is significantly impacted by female age, with live birth rates (LBR) 
decreasing as maternal age increases (Liu et al., 2011). This trend was generally seen 
in women in their mid-30’s and onward, which continues until menopause. Some 
studies show that normal fertilization rate is not affected by advanced maternal age, 
although it does show an increase in abnormal fertilization rate (Grøndahl et al., 2017). 
Lawler et al. (2007) investigated the relationship between entry into syngamy and first 
cleavage as predictors of implantation on day 2 of embryo development, as well as 
the inter-relationship of female age. Pronuclear presence was evaluated 16 to 18hours 
post insemination and a second evaluation was done at 23 to 24 hours post 
insemination for ICSI and IVF. They concluded that there is a significant correlation 
between time of entry into syngamy and female age, with earlier syngamy associated 
with females under the age of 36 years (Lawler et al., 2007). They also determined 
that implantation potential was higher for day 2 embryos when entry into syngamy 
occurred before 23 to 24 hours post insemination. 
Apart from female age, female diagnoses are established by investigating tubal 
patency, ovulatory function, and standard fertility tests. Infertility is defined as the 
inability to conceive after a minimum of 12 months of frequent, unprotected intercourse 
during the ovulatory period of the female (Ray et al., 2012, Gelbaya et al., 2014, 
Abdelazim et al., 2018). 
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Tubal patency was usually assessed through hysterosalpingogram and/or 
laparoscopy. The adhesion or obstruction of the Fallopian tubes could be due to 
infections, endometriosis or previous surgery. The prevalence of tubal factor infertility 
in sub-fertile groups is approximately 14% (Gelbaya et al., 2014). 
Endometriosis is characterized by endometrial-like tissue present outside the uterine 
cavity and its mechanism associated with female infertility is not completely 
understood (Dong et al., 2013). A retrospective study by Dong et al. (2013) in patients 
with endometriosis who underwent IVF/ICSI treatment has shown that pregnancy 
outcomes were similar to patients with tubal factor diagnosis. Although there is 
contradicting literature that suggest that patients with endometriosis have poorer 
outcomes (Gelbaya et al., 2014). Literature shows that 30% to 50% of infertile patients 
suffer from endometriosis (Dong et al., 2013, Gelbaya et al., 2014). 
Normal ovulatory function is assessed by the evaluation of different ovulatory 
indicators such as, a rise in basal body temperature, changes in cervical mucus, serum 
luteinizing hormone surge or mid-luteal progesterone levels (Ray et al., 2012). 
Polycystic ovarian syndrome (PCOS) is one of the causes of ovulatory dysfunction. 
The prevalence of PCOS is between 18% to 25% (Heijnen et al., 2005, Gelbaya et al., 
2014). Heijnen et al. (2005) conducted a meta-analysis between PCOS and non-
PCOS patients, in which it was concluded that patients in both these groups had 
similar pregnancy and LBR per cycle.  
Idiopathic (also known as unexplained) infertility was diagnosed after all possible 
female causes are excluded and male semen analysis was normal (Ray et al., 2012, 
Gelbaya et al., 2014, Abdelazim et al., 2018). According to the three studies cited, the 
prevalence of idiopathic fertility is between 8% and 40%. Unexplained fertility could be 
due to undetected problems in the reproductive process or lower fecundity of the 
couple. The prevalence of idiopathic infertility varies according to female age, inclusion 
criteria of the study population, as well as the investigations done before the diagnosis 
was made (Gelbaya et al., 2014).  
 
Stellenbosch University  https://scholar.sun.ac.za
25 
 
 Fertilization and oocyte activation  
Fertilization consists of a sequence of events that leads to the merging of a 
spermatozoon and oocyte, which entails the fusion of their haploid genomes and 
cytoplasmic contents in order to result in a diploid zygote (Klinovska et al., 2014). The 
oocyte and the spermatozoon need to be mature for fertilization to be able to occur in 
the ampulla of the oviduct (Georgadaki et al., 2016). Spermatozoa need to travel to 
the fallopian tubes after semen has been deposited in the vagina. This journey through 
the acidic environment of the vagina, passing through the cervical mucus, uterus and 
proceeding to the fallopian tubes, selects and eliminates many spermatozoa and 
results in only a few hundred spermatozoa reaching the oocyte (Anifandis et al., 2014). 
It is hypothesised that the cumulus mass of the oocyte secretes chemo-attractants 
that assist the spermatozoa to direct themselves towards the oocyte (Anifandis et al., 
2014). Spermatozoa need to penetrate the cumulus cells, as well as bind to and 
penetrate the zona pellucida (ZP) and plasma membrane, in order to successfully 
fertilize the oocyte. The penetration is only possible if the spermatozoa have 
undergone essential biochemical and biophysical changes. These changes are 
brought about by the process of capacitation and hyperactivation, also allowing the 
acrosome reaction to occur. This process involves the increase in pH and calcium ion 
(Ca+) levels. 
Capacitation is the activation of spermatozoa and is accompanied by hyperactivation, 
an elevated energy state which increases motility by vigorous flagellar movement 
(Georgadaki et al., 2016); allowing detachment from the isthmus epithelium (Anifandis 
et al., 2014). Capacitation involves the removal of cholesterols and other inhibitory 
factors such as sterols, and seminal plasma proteins (Anifandis et al., 2014, 
Georgadaki et al., 2016). Only spermatozoa that have completed capacitation have 
the ability to bind to and penetrate the ZP and fertilize the oocyte (Georgadaki et al., 
2016).  
Oocyte activation involves several physical and chemical changes that occur in the 
oocyte. The first is an increase in ionic permeability of the plasma membrane (Elder 
and Dale, 2010), followed by the cortical reaction and ZP transformation, in order to 
prevent further penetration by other spermatozoa.  
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The extracellular matrix of the ZP comprises of three glycoproteins, ZP1, ZP2 and ZP3 
(Georgadaki et al., 2016) and the cumulus oophorous consists of granulosa cells that 
contain hyaluronan (Georgadaki et al., 2016). The binding of the spermatozoon to the 
ZP3 protein triggers the acrosome reaction, which is an exocytosis reaction that 
releases enzymes such as hyaluronidase to disintegrate the cumulus oophorus 
(Anifandis et al., 2014, Georgadaki et al., 2016). Binding to the ZP activates 
mechanisms that increase Ca+ concentration and pH levels (Anifandis et al., 2014). 
The acrosome membrane fuses with the plasma membrane of the spermatozoa, 
releasing peptidases and enzymes such as acrosine in order to penetrate the ZP 
(Anifandis et al., 2014).  
After the spermatozoa have bound to the ZP, and the acrosome reaction is initiated, 
acrosome-reacted spermatozoa are able to penetrate the ZP. This is due to the fact 
that the acrosome releases enzymes which also digest through the ZP, creating a 
pathway for the spermatozoa to enter the oocyte. These enzymes include acrosin, 
which is a protease, testicular serine protease 5 (TESP5) and a multi-subunit 
proteasome that has proteolytic characteristics (Anifandis et al., 2014). The acrosome 
reacted spermatozoon which successfully penetrates the ZP and enters the 
perivitelline space is able to fuse with the oolemma of the oocyte (Klinovska et al., 
2014). 
The cortical reaction occurs next in order to prevent polyspermy after one 
spermatozoon has successfully bound to the oocyte (Georgadaki et al., 2016). This is 
achieved by modifying the ZP to be impenetrable to other spermatozoa. This process 
is initiated by the increase in Ca+ from the cortical smooth endoplasmic reticulum in a 
wave like manner, causing the cortical granules to rupture (Georgadaki et al., 2016). 
The Ca+ increase activates the protein exchanger, which increases the pH by influx of 
Na+ and efflux of H+ (Georgadaki et al., 2016). The release of the cortical granule 
contents leads to changes in the extracellular matrix, such as hardening of the vitelline 
envelope, and enzymes digest the ZP3 and ZP2 spermatozoa receptors to avoid any 
further binding of spermatozoa (Georgadaki et al., 2016).  
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During gamete fusion, the membranes of the spermatozoon and oocyte fuse, which is 
believed to be dependent on the lipid membranes found on both gametes (Coward 
and Wells, 2013). Spermatozoa that have undergone the acrosome reaction are able 
to fuse due to the fact that essential factors on the membrane are exposed or altered 
by the process (Klinovska et al., 2014). The equatorial region on the spermatozoon 
head is proposed to be the area where fusion is initiated (Klinovska et al., 2014). The 
oocyte plasma membrane also appears to consist of a microvillar-free section that 
covers the meiotic spindle and microvillar-rich area, where fusion only occurs on the 
microvillar-rich part (Klinovska et al., 2014). The fact that fusion occurs at specific 
regions on both gametes, might indicate that these regions contain a certain protein 
and lipid composition (Klinovska et al., 2014). The fusion of the two gametes entail the 
merging of the oocyte’s plasma membrane with the spermatozoon, as well as the 
combining of the cytoplasm’s. 
After gamete fusion, the oocyte needs to be activated in order to transcribe the 
necessary proteins and RNAs for fertilization and embryogenesis. Spermatozoa 
introduce the oocyte activating factor, which modifies the regulatory components for 
calcium homeostasis in the oocyte (Tesarik, 2005). Activation ensures that a mature 
oocyte is able to develop into a growing embryo. The mechanism by which activation 
is initiated is still unknown, but there are many models suggesting that it could be a 
calcium influx, membrane receptors or a soluble sperm factor model. 
Meiosis is reinitiated and meiosis II is completed (see Figure 1.2): Prophase II, 
metaphase II, anaphase II, telophase II and final cytokinesis results in a haploid 
maternal genome and extrusion of the second polar body (Pierce, 2012). The maternal 
haploid genome is then able to combine with the paternal haploid genome. The haploid 
genomes of both gametes are visualized when the two pronuclei appear in the oocyte. 
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Figure 1.2. Diagram of the second meiotic phase.  
Image by: Ali Zifan - Own work; Used information from Campbell Biology (10th Edition) by: Jane B. 
Reece & Steven A. Wasserman, CCBY-SA4.0, 
https://commons.wikimedia.org/w/index.php?curid=49630204 
Maternal RNA and proteins can now be transcribed and translated; as well as the 
cytoskeleton rearranged in order to sustain embryo development and growth (Pierce, 
2012). This process results in the eventual rise of a zygote (Pierce, 2012).  
 Pronuclei formation and pronuclear (PN) morphology 
The extrusion of the second polar body is the first sign of fertilization, although this 
does not indicate normal fertilization (Campbell and Fishel, 2015). Normal fertilization 
of an oocyte is characterized by pronuclear formation and the presence of two 
pronuclei (PN) and two polar bodies (Balaban et al., 2011). Studies have shown that 
post insemination timing of the second polar body extrusion was indicative of embryo 
implantation and morphology (Campbell and Fishel, 2015). The optimal time for 
second polar body extrusion and embryo implantation was investigated by Aguilar et 
al. (2014) in a TL study and shown to be between 3.3 and 10.6 hours post ICSI.  
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Nuclear membranes form around each of the decondensed male and female 
chromatin, creating two PN that contain the two sets of haploid chromosomes. The 
female pronucleus forms closer to the second polar body and appears simultaneously 
or slightly after the central formation of the male pronucleus (Campbell and Fishel, 
2015). In the case of a zygote having one or three PN, laboratories generally annotate 
these as abnormal fertilizations.  
The pronuclei need to be of equal size and in a central position; if they are not located 
centrally, it could be an indication of failed mechanisms within the fertilization process 
(Scott, 2003). The polar axis is formed after sperm entry and oocyte activation. At this 
stage, it is essential that the PN align correctly and that the polar axis forms for normal 
syngamy and first cleavage to take place (Scott, 2003). The pronuclear morphology 
has been used in order to predict arranged embryo development (Balaban et al., 
2011). Structures visible within the pronuclei, known as nucleolar precursor bodies 
(NPBs), have been used as embryo quality criteria based on their number and pattern 
display (Elder and Dale, 2010). However, it has been noticed with TL incubation and 
evaluation that these NPB patterns change and the arrangements are dynamic 
(Azzarello et al., 2012). 
In the cell cycle, mitosis cell division consists of two phases. The interphase, which 
consists of the G1 (phase of cell growth), G0 (Non-dividing phase), Synthesis-phase 
(DNA duplication stage) and G2 (cell preparation for mitosis), and the M-phase which 
is the mitotic phase when cell division occurs (see Figure 1.3). 
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Figure 1.3. Diagram depicting the cell cycle consisting of the interphase and M phase. Image by: 
OpenStax College, Biology, https://cnx.org/contents/1tJ55Ot6@7/The-Cell-Cycle. 
Studies using TL have shown that timing of pronuclear fading has a significant effect 
on embryo implantation, where a shorter timing of PN fading was linked to better 
implantation (Aguilar et al., 2014). The length of the S-phase is determined from PN 
appearance until PN fading and Masai et al. (2010) reported a duration time for the S-
phase of 7 to 8 hours. Aguilar et al. (2014) reported better implantation of embryos 
with a S-phase duration of 5.7 to 13.8 hours compared to embryos with a longer S-
phase duration of >13.8 hours.  
Hewitson et al. (2000) reviewed the possibility of the initiation of the S-phase differing 
between IVF and ICSI insemination methods, using rhesus monkey zygotes as a non-
human model. They found that ICSI fertilized zygotes had abnormal nuclear 
remodelling which resulted in delayed onset of DNA synthesis. They concluded that 
ICSI possibly may result in chromatin damage when de-condensation of DNA occurs, 
accentuating the need for better pre-clinical assessment prior to use and acceptance 
of treatment.  
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The result of delayed onset of the S-phase, in the beforementioned study, was 
contradicted by Cruz et al. (2013) who showed that the differences in kinetic parameter 
time points between IVF and ICSI disappeared when pronuclei fading was used as the 
reference time point (t0) rather than time of insemination.  
The fusing of the two pronuclei takes place during syngamy which is defined as the 
time of PN fading (Aguilar et al., 2014). This takes place after the S-phase has been 
completed and before the M-phase initiates.  
The S-phase is then preceded by the G2 and M phase. Meseguer et al. (2011) reported 
a time duration of 4.04 hours from the time of PN fading until the time of first cell 
cleavage, which delineates the G2 and M phases. 
A few studies have investigated certain fertilization events such as pronuclei 
morphokinetics and syngamy timing and have indicated positive correlations with 
embryo quality. However, it is noted that studies differ in reference time-points and 
calculations used to investigate these events. 
 Syngamy and role of spermatozoa in the embryo genome  
The fertilization process continues with the fusion of two haploid genomes, namely the 
maternal and paternal genomes to produce a diploid zygote (Coward and Wells, 
2013), also known as syngamy. It has been proposed by Balaban et al. (2011) to 
evaluate syngamy at 23 +/- 1 hour post insemination. 
After pronuclear formation, the pronuclei gradually migrate to the centre of the oocyte, 
until they are adjacent to each other. The pronuclear membranes disintegrate and the 
mitotic metaphase spindle forms. Between 18 and 24 hours after gamete fusion, the 
two sets of chromosomes come together in syngamy. Syngamy is described as the 
merging of maternal and paternal DNA, and can be visualized when the two pronuclei 
fade (Aguilar et al., 2014).  
The mitotic spindle is the structure that ensures the correct distribution of genomic 
material (Palermo et al., 1997). The mitotic spindle is formed by the centrosome, which 
regulates the orientation of the microtubules to allow even dispersal of chromosomes 
(Palermo et al., 1997).  
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Spermatozoa are the source of the functional centrosome after spermatozoa entry 
into the oocyte, which lacks centrioles (Palermo et al., 1997). The function of the 
centrosome is to organize the microtubule network and nucleate the aster, which 
contains the microtubules (Palermo et al., 1997). Previous research has proposed the 
theory that only one centriole is inherited by the zygote from the spermatozoa, but this 
has brought about confusion with regards to the number of centrioles provided by the 
spermatozoon (Schatten and Sun, 2009, Fishman et al., 2018). The spermatozoon is 
able to provide two centrioles for each dividing daughter cell, leading to the 
unanswered question as to where the second centriole is coming from.  
The spermatozoa’s centriole-centrosome complex, comprises of a proximal centriole 
(PC) and distal centriole (DC). The PC and DC is located in the neck region of the 
spermatozoa where the basal plate and flagellum of the sperm join (Schatten and Sun, 
2009, Fishman et al., 2018). The dogma in literature was that the centrioles and 
surrounding pericentriolar material (PCM) was modified during spermatogenesis, 
called centrosome reduction. It was believed that the DC disintegrates, leaving only 
the functional PC.  
However, new findings have confirmed a second atypical centriole, which is delivered 
to the zygote by the spermatozoa (Fishman et al., 2018). Fishman et al. (2018) found 
that during spermatogenesis, the centrosome is remodelled as proteins are 
rearranged and enables spermatozoa to deliver two centrioles, the known typical 
centriole and the newly discovered, atypical centriole. This is achieved when proteins 
are redistributed amongst the PC, DC and PCM during spermatogenesis, which 
results in the DC not being disintegrated, but rather being remodelled into an 
alternative composition.  
The spermatozoa thus provides two centrioles to the zygote, the typical centriole (PC), 
atypical centriole (DC) and the remodelled structural PCM (Fishman et al., 2018). They 
found that the DC recruits the PCM in vivo to form the daughter centriole, providing 
two functional centrosomes which position at opposite spindle poles in the zygote. It 
is still unknown what the purpose of the remodelled structure is. 
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The spermatozoa play a role in the events that precede syngamy and directly affect 
syngamy itself. During male pronuclear formation, elongated microtubules originate 
from the spermatozoa centrosome (Van Blerkom, 1996). These microtubules come 
into contact with the female pronucleus to stabilize close proximity of the two PNs 
before syngamy occurs (Van Blerkom, 1996, Palermo et al., 1997). The event of 
microtubule formation occurs after penetration but before DNA de-condensation and 
nuclear expansion (Van Blerkom, 1996). Figure 1.4 illustrates this process.  
 
Figure 1.4. a) Illustration of the meiotic spindle during the first polar body extrusion and b) illustrates 
the meiotic spindle of the second polar body extrusion after spermatozoa insemination; where the 
mitotic spindle is seen after pronuclei undergo syngamy. Image sourced from: (Palermo et al., 1997). 
When the PNs start to rotate, the PN of the male and the female need to align. In the 
case of failed alignment of polar bodies and pronuclei, abnormal fertilization and 
cleavage can occur (Balaban et al., 2011).  
Aguilar et al. (2014) conducted a retrospective study to describe timings of fertilization 
events in implanted and non-implanted embryos and showed that timings of second 
polar body extrusion, pronuclear fading and the length of the S-phase was linked to 
implantation.  
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Azzarello et al. (2012) investigated whether PN morphology and PN fading could 
predict live birth outcome. Time of PN fading was calculated from time of insemination 
until PN breakdown. They showed that embryos with PN fading earlier than 20.45 
hours post insemination did not result in live birth. They also reported that PN 
morphology changes over time and showed no significant difference in live birth. 
Wirka et al. (2014) investigated the association with abnormal syngamy, abnormal first 
cytokinesis, abnormal cleavage, chaotic cleavage and embryo morphology and 
development, using the Eeva Time lapse system. They also investigated the syngamy 
timing defined as time from PN disappearance until time of first cell cleavage. They 
defined abnormal syngamy as the presence of disordered pronuclei movement and 
delayed dispersion of the nuclear envelopes. Results from the study showed that the 
mean syngamy time was significantly shorter for embryos displaying abnormal 
syngamy (1.8 ± 1.4 hours) in comparison to embryos without abnormal syngamy (2.4 
± 1.8 hours). It was also reported that embryos with abnormal syngamy had a 
significantly lower blastocyst formation rate (21.5%) in comparison to normal syngamy 
embryos (44.9%). In addition, only 30% of the abnormal syngamy embryos resulted in 
good or fair quality blastocysts in comparison to 60% of the normal syngamy embryos, 
which resulted in good or fair quality blastocysts. 
Ueda et al. (2012) reported on the relationship between the timing of syngamy and 
human embryonic development using time-lapse cinematography. This study defined 
syngamy time duration as second polar body extrusion until pronuclear fading. They 
showed that syngamy time for IVF was 21.2 ± 3.6 hours and 20.8 ± 3.6 hours for ICSI, 
which had no significant difference. Good quality embryos had a syngamy time of 20.0 
± 3.3 hours, in comparison to poor quality embryos of 22.1 ± 4.3 hours, which was 
significant. Results also showed that abnormally fertilized embryos had longer 
syngamy times of 25.1 ± 6.3 hours, which showed a significant delay compared to 
normally fertilized embryos. 
Early cleavage evaluation and syngamy determination varies greatly between 
laboratories (Balaban et al., 2011). Many studies have shown that the first cell 
cleavage can predict embryo quality and implantation (Balaban et al., 2011). Early and 
late syngamy timing or early cleavage could have a poorer prognosis.  
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Embryo cleavage observation schedule at optimal cleavage rates were determined at 
the Istanbul consensus workshop as: Day 1 (fertilization check 17 ± 1 hours post 
insemination and syngamy check at 23 ± 1 hours post insemination), 2-cells (26 ± 1 
hours post-ICSI, 28 ± 1 hours post-IVF), Day 2, 4-cells (44 ± 1 hours), and Day 3, 8-
cells (68 ± 1 hours) (Balaban et al., 2011). Uneven cleavage is classified as abnormal, 
as it has been correlated to chromosome aberrations and multinucleation (Hardarson 
et al., 2003). 
The fact that the spermatozoa has such an important contribution to syngamy and 
possibly early embryogenesis, suggests that the spermatozoa play a role during 
fertilization, as well as embryo development. Some studies state that male factor 
infertility should further be investigated with regards to syngamy (Wirka et al., 2014). 
Recently, evidence has suggested increased epigenetic effects from the male 
spermatozoon, which may alter DNA methylation, non-coding RNA and histone 
modifications taking place during gametogenesis and early embryogenesis 
(Rodenhiser and Mann, 2006, Denomme et al., 2018).  
Sperm DNA inheritance and epigenetic imprinted DNA play a key role in fertilization 
and embryo development (Denomme et al., 2018). Many studies link poor male 
diagnosis with abnormal epigenetic characteristics, although there is little evidence of 
what the effects thereof are after fertilization (Denomme et al., 2018).  
Castillo et al. (2018) conducted a review on the spermatozoa proteome in order to 
associate the spermatozoa’s proteins with function during preimplantation 
embryogenesis. The review included the proteomes from the spermatozoa, oocyte 
and early embryo. Complicating the assessment of spermatozoa function is the fact 
that oocyte and early embryo biological matter and information is minimal, which 
restricts research on developing embryo proteomes.  
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Figure 1.5. Time-line according to days of early embryo development after fertilization up to 
blastulation. Decline of DNA methylation of the paternal and maternal genes are indicated, as well as 
minor gene activation prior to the Embryonic Genome Activation. Sex-specific marks at imprinted genes 
are indicated at day 3 of development. Figure sourced from Castillo et al. (2018). 
The fertilization process, as previously described, is an intricate process that involves 
the oocyte as well as the spermatozoa. The analysis of the sperm proteome identified 
103 proteins which are involved in the fertilization process (Castillo et al., 2018). After 
formation of the zygote, the chromatin undergoes many changes, such as replacement 
of male protamines with maternal histones. It has been determined that from the 2-cell 
stage up until the 4-8 cell embryo stage, one can observe some minimal gene 
activation. This transcription of genes might be due to the fact that DNA undergoes 
de-methylation, allowing gene activation and transcription into proteins. The embryo’s 
own genome is only activated around the 4-8 cell stage, as depicted in Figure 1.5. The 
embryo synthesizes its own proteins from its genome, with many proteins possibly 
originating from the paternal or maternal RNA. Castillo et al. (2018) also observed 
some critical proteins which play a role during early embryogenesis that might be 
paternally derived. Knowledge about paternal originating proteins and their role during 
fertilization and pre-implantation embryogenesis is still very limited and needs to be 
studied further. 
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Denomme et al. (2018) studied the outcomes of patients with oligo-astheno-
teratozoospermia (OAT), who had undergone preimplantation genetic testing (PGT) 
and euploid embryo transfer. They also looked at the global methylome and 
transcriptome of the blastocysts from these patients. They found that there was an 
increased miscarriage rate in OAT patients compared to normal male diagnosis 
patients. The methylation and transcriptome of OAT male factor patients resulted in 
aberrations which translate in epigenetic events that consequently lead to reduced 
reproductive potential of the embryo’s associated with poor male sperm (Denomme et 
al., 2018). It is clear that although this study supports other literature, indicating that 
the spermatozoon influences embryo competence, more in-depth studies are still 
required.  
 Blastulation and the role of male prognosis 
In the ideal embryo development scenario, successful fertilization and syngamy is 
followed by the cleavage stages of embryo development, from 2 cells on day 1 to more 
than 8 cells on day 3, and continues to form a compacted morula and finally a 
blastocyst on day 5. The morula stage should be reached approximately 4 days after 
fertilization, which is when it enters the uterus (Moore et al., 2011). A fluid-filled cavity 
starts to form inside the morula, known as the blastocoel. The blastocoel continues to 
expand as fluid is transported through the sodium transport channels into the cavity. 
This helps to maintain osmotic balance by incorporating water with the influx of sodium 
ions (Sepúlveda et al., 2011). The expansion of the blastocoel, together with other 
mechanisms such as enzymatic digestion, leads to hatching or breaching of the zona 
pellucida (ZP), in order for the trophectoderm epithelium to come into contact with the 
endometrial lining for implantation of the embryo (Campbell and Fishel, 2015).  
Incubation and medium advances, as used in TL systems, has facilitated extended 
embryo culturing periods up to blastocyst stage on days 5 and 6. Blake et al. (2007) 
performed a meta-analysis showing that day 5 blastocyst transfer in comparison to 
day 3 transfers improved pregnancy rates and live birth outcomes. The Glujovsky et 
al. (2012) Cochrane review reported an increased live birth rate for blastocyst culture, 
but no difference in clinical pregnancy or miscarriage rates between early cleavage 
and blastocyst transfers. 
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Many studies have been conducted on factors impacting blastocyst development. 
Westphal et al. (2003) investigated whether ICSI cycles had lower blastocyst formation 
and pregnancy outcome compared to conventional IVF. ICSI was used as 
insemination method for patients who had an indication based on abnormal semen 
parameters or previously failed IVF. Results showed no difference between ICSI and 
IVF with regards to blastulation (78% in IVF and 73% in ICSI) or viable pregnancy 
rates (51.4% in IVF and 55% in ICSI). 
Sepúlveda et al. (2011) investigated the outcomes in IVF and ICSI cycles of different 
female age groups with regards to blastocyst formation, implantation, pregnancy and 
miscarriage. The groups were divided into oocyte donors (control group), <35 years, 
35-39 years and >39 years. Results showed that all groups of patient ages had similar 
blastulation rates (40.2%, 37.2%, 34.2%) and only the control group had a different 
blastocyst formation (43.6%), pregnancy and implantation rate. They reported that 
patients over 39 years had a significantly higher miscarriage rate of 59.1% compared 
to the other groups (oocyte donors = 13.2%, <35 years = 12.7% and 35-39 years = 
21.3%). 
In addition to blastulation, the characteristics of the blastocyst is also of importance to 
determine quality and implantation potential in embryo selection. The process of 
blastulation results in a blastocyst consisting of the blastocoel, inner cell mass (ICM) 
and the trophectoderm epithelium (TE) layer, which can be distinguished from each 
other as seen in Figure 1.6. 
The outer layers of the blastocyst form the TE, which is a thin layer of special epithelial 
cells giving rise to the embryonic placenta (Moore et al., 2011). The centrally located 
blastomeres form the ICM, which gives rise to the foetus (Moore et al., 2011). 
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Figure 1.6. Example of blastocyst and features that are evaluated are indicated on the figure. Artwork 
by (Elder and Dale, 2010). 
Grading of blastocyst morphology is the main method being used routinely for embryo 
selection and was first described by Schoolcraft et al. (1999). Many laboratories have 
based their embryo grading on the Veeck or Gardner scores (Schoolcraft et al., 1999, 
Veeck and Zaninovic, 2003), of which this study uses a modified Gardner score (See 
Appendix G). The Gardner grading of the blastocyst expansion, TE and ICM is 
described below. 
Blastocyst expansion:  
1 – Blastocyst fills the perivitelline space (PVS), trophectoderm is aligned to the zona   
      pellucida (ZP), where the ZP is still its original thickness.  
2 – Blastocyst begins to expand and ZP is two thirds its original thickness.  
3 – ZP is one half to one third its original thickness.  
4 – ZP is very thin, but no hatching is visible yet.  
5 – ZP is torn, trophectoderm bulges out of ZP.  
6 – Blastocyst is more than 50% hatched out of the ZP.  
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Inner Cell Mass (ICM):  
A – Many cells, tightly packed together, with no granularity.  
B – Some cells, packed looser, with slight granularity.  
C – Few cells, very loosely packed, granular and dark.  
Trophectoderm epithelium (TE):  
A – Many cells (>80%) epithelial cells with clear nuclei, which multiply during   
       expansion, no granularity.  
B – 50 – 75% Epithelial cells, some areas have stretched TE, few granular areas.  
C – TE are few and stretched, with granular and dark areas.  
Many studies have been conducted to evaluate the effect of the three blastocyst 
parameters on ART outcomes such as implantation and pregnancy.  
Desai et al. (2016) reported on which blastocyst features independently predicted 
successful pregnancy and live-births from vitrified-warmed embryos. Results showed 
that blastocyst expansion grade was predictive of successful outcomes irrespective of 
ICM or TE. However, in their univariate analysis, ICM and TE grading also correlated 
positively with abovementioned outcomes.  
Du et al. (2016) conducted a similar study to Desai et al. (2016), investigating the effect 
of all three parameters of blastocyst grading. Their findings showed the degree of 
blastocoel expansion was predictive of live birth in fresh and vitrified-warmed single 
embryo transfer. ICM grade was significantly related to live birth in fresh cycles when 
using a univariate mode, but was not seen in the multivariate logistic analysis. Neither 
ICM nor TE was correlated with live birth using logistic regression analysis. Their 
conclusion was that blastocoel expansion was a better predictor of live birth than ICM 
or TE. 
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Zaninovic et al. (2001) conducted a retrospective study to correlate blastocyst 
expansion, ICM or TE quality as separate and individual parameters to implantation. 
They found that there was no significant difference between degree of blastocyst 
expansion or ICM morphology and implantation rate, however, they showed a 
significantly higher implantation rate when an embryo with an A-grade trophectoderm 
(76%) was selected for transfer. The B- and C-grade trophectoderm embryos 
transferred had a lower implantation of 56% and 50% respectively. In addition, the 
study reported that an A-grade TE morphology correlated with the survival of 
blastocysts after thawing, compared to B- and C-grades (85%, 63% and 62% 
respectively). It was concluded that TE has a greater impact on implantation than 
blastocyst expansion and ICM quality, attributed to the fact that the TE plays a critical 
role during attachment to the uterine wall. 
Ahlström et al. (2011) and Hill et al. (2013) both did retrospective studies to investigate 
each blastocyst morphological parameter and the relation to live birth outcome. The 
results of both studies showed that TE had a stronger correlation to implantation and 
live birth outcome than ICM. Similar results were shown more recently by Ebner et al. 
(2016) who conducted a prospective study to determine whether ICM size and quality, 
TE morphology and cell number, or expansion correlated with ART outcome in both 
fresh and frozen embryo transfer cycles. Results showed that TE quality and cell 
number was the strongest predictor of treatment outcome, and correlated with live 
birth and miscarriage. Therefore, they suggested that TE be prioritised before ICM 
grading during embryo selection.  
Thompson et al. (2013) also did a retrospective study on SET cycles to determine 
which blastocyst morphology parameters better predicted CPR and LBR. They 
categorized expansion into early, expanded and hatching blastocysts. They 
categorized ICM and TE into poor, fair and good scorings. Based on their results, it 
was concluded that better trophectoderm morphology and further blastocyst 
progression showed higher CPR and LBR, therefore being the most important 
parameters to use when selecting an embryo for transfer. ICM did not result as a 
predictive indictor of CPR or LBR. Younger patients also showed higher CPR and 
LBR.  
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TL technology allows embryologists to observe cleavages and the start of blastulation 
(tSB), which is annotated as the time point where the first sign of formation of a 
blastocoel cavity is observed (Campbell and Fishel, 2015). Some of the early embryo 
kinetic parameters have been studied using TL to predict blastulation. 
A study done by Wong et al. (2010) identified a combination of three cleaving 
morphokinetic data parameters i.e. first cell cytokinesis duration, time between the first 
mitosis completion and second mitosis initiation and the time duration between the 
second and third mitoses, to predict blastocyst formation using their algorithms before 
day 4 of embryo development and reported a 93 to 94% sensitivity and specificity. 
Lemmen et al. (2008) investigated the events after fertilization to identify markers that 
could be correlated to good quality embryos on day 2 and implantation. Their results 
showed correlations between earlier PN disappearance after fertilization, earlier first 
cell cytokinesis and increased number of blastomeres on day 2 of embryo 
development. They also showed correlations with pregnancy rate when nuclei 
appeared synchronously after first cell cytokinesis, of which time range references 
were not reported. Two previously discussed studies showed contradictory findings 
compared to that of Lemmen et al. (2008). Azzarello et al. (2012) showed no live birth 
when zygotes had too early PN fading post insemination (20.45 hours). Meseguer et 
al. (2011) also showed that first cell cytokinesis taking place too early could be 
detrimental to implantation. 
Desai et al. (2014) investigated the time differences of kinetic cell divisions between 
embryos forming blastocysts and their potential for implantation using the 
EmbryoScopeTM. Kinetic time points from insemination was assessed using TL, which 
included time to syngamy (tPNf), t2, time to two cells (c), 3 cells (t3), 4 cells (t4), 5 
cells (t5), 8 cells (t8), morula (tM), start of blastulation (tSB); time to blastocyst (tBL); 
expanded blastocyst (tEBL). They also looked at the duration of the second (cc2) and 
third (cc3) cell cycles, the t5-t2 interval and the time duration of synchronous divisions 
s1 (t2 - tPNf), s2 (t4 - t3) and s3 (t8 - t5). Results showed that tPNf, t2, t4, t8, s1, s2, 
s3 and cc2 were significantly different in embryos forming blastocysts compared to 
embryos either failing to reach blastulation or forming poor quality blastocysts.  
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Time to syngamy, defined as time from ICSI to PN fading, was also investigated in 
relation to blastulation. Time to syngamy was 24.8 ± 2.6 hours in good quality 
blastocysts selected for transfer of which implanted blastocysts showed a significantly 
shorted syngamy timing of 24.1 ± 2.5 hours compared to 26.2 ± 2.7 hours in those that 
did not implant. Time to syngamy was significantly longer with 26.8 ± 8.3 hours in poor 
quality and non-blastulating embryos compared to the transferred blasts and frozen 
blastocysts (25.2 ± 3.0 hours). 
Their comparisons of embryo morphokinetics in implanted embryos and non-
implanted embryos suggested that embryo kinetic markers may differ in the ability to 
reach blastocyst stage. They also reported a CPR of 72% and an implantation rate of 
50% in their study. 
Milewski et al. (2015) also used morphokinetic parameters from TL EmbryoScopeTM 
incubator culture to predict blastocyst development. They developed a predictive 
multivariate model algorithm from timings of two- and five cells and intervals between 
second and third division. They concluded that such a model can enable embryologists 
to identify embryos with high reproductive potential earlier in embryo development and 
can subsequently shorten embryo incubation. 
Knowledge of the role and functions of the spermatozoa during early embryo 
development and blastulation is still controversial, as data is challenging to assess. 
Desai et al. (2009) investigated the paternal effect from epidydimal and testicular 
sperm sources by looking at zygote formation, embryonic cleavage and genomic 
activation. The paternal genome activation in ICSI cycles were evaluated by using 
embryonic compaction and blastulation as indication of zygotic transcription onset, 
which occurs at the 4 to 8-cell stage, as mentioned before. Results showed no 
difference in compaction or blastulation rates, respectively, amongst epididymal (74%, 
38%), obstructive azoospermic testicular (69%, 42%) or non-obstructive azoospermic 
testicular (79%, 38%) spermatozoa. The only parameter significantly affected in non-
obstructive azoospermic testicular cases was the fertilization rate. 
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French et al. (2010) did a retrospective review to investigate whether Tygerberg strict 
criteria correlates with outcomes in ICSI cycles. They divided the sperm morphologies 
into subgroups: 0%, 1%, 2%, 3%, 4%, 5–7%, and >7% normal sperm morphology. 
They did not observe any difference in blastulation rate amongst the groups, which 
was from 41% to 50%. They found that fertilization, implantation, pregnancy and live 
birth rates were not statistically different between the groups and no effect was 
observed on blastocyst development or quality. Surprisingly, the study results showed 
a higher percentage of good quality blastocysts in the most severely teratozoospermic 
group with 0% normal forms in comparison to patients with ≥5% normal forms (37% 
vs. 28%). They attributed this outcome to patient etiology distribution with less 
prevalence of female factor infertility in the severely teratozoospermic group. 
Hickman et al. (2013) investigated the effect of sperm origin, maternal age and embryo 
ploidy on embryo morphokinetics using TL. Comparisons were made between 
surgically retrieved and ejaculated sperm, embryos from older (≥37 years) and 
younger (≤36 years) female patients, and genetically abnormal and normal 
chromosome screening of embryos. They showed that sperm source and maternal 
age contributed to embryo morphokinetics. Embryos resulting from surgically retrieved 
spermatozoa had delayed morulation, and blastocyst hatching, but had a shorter 
duration until two cell stage, compared to those from ejaculated sperm. Younger 
patients reached morulation, expanded and hatching blastocyst stages faster than 
older patients. Lastly, morphokinetics were not affected by ploidy status. They 
concluded that sperm source and maternal age contributes to embryo morphokinetics, 
suggesting the role of the spermatozoa in the first cleavage and embryo development 
after embryonic genome activation. 
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Bartolacci et al. (2018) conducted a retrospective analysis to investigate the impact of 
male age, spermatozoa concentration and motility on blastulation rate, fertilization 
rate, top quality blastocyst formation rate and pregnancy rate in ICSI cycles. They 
divided the male groups into four according to concentration based on the WHO 
criteria (2010). Results showed a significant difference in fertilization and blastulation 
rates, but no difference in top quality blastocyst formation rate or ongoing pregnancy 
rates. Blastulation rates were defined as the number of blastocysts formed per oocyte 
cultured and differed from the poorest group (spermatozoa concentration < 1 x106 per 
ml): 50.0 (33.3–66.3%) compared to the better group (spermatozoa concentration ≥ 
15 x106 per ml): 55.6 (40.0–75.0%).  
Mazzilli et al. (2017) investigated the effect of male factor on the outcomes in ICSI 
cycles in combination with pre-implantation genetic testing for aneuploidies (PGT-A). 
They divided the cycles into five groups according to male spermatozoa parameters: 
normozoospermia, moderate male factor, severe oligo-astheno-teratozoospermia, 
obstructive azoospermia, and non-obstructive azoospermia. Results showed a 
significant difference in fertilization rate between normozoospermia (77.2%) and all 
four other groups (74.8%, 68.7%, 67.3% and 53.1% respectively). Blastulation rate 
per fertilized oocyte differed significantly in the non-obstructive azoospermia group 
(40.6%) compared to the normozoospermia group (49.3%). The moderate male factor 
(48.6%), severe oligo-astheno-teratozoospermia (48.0%), and oligo-
asthenozoospermia (45.5%) groups showed similar blastulation rate to the 
normozoospermia group (49.3%). The timing of blastocyst development was affected 
by obstructive and non-obstructive azoospermia. There was no correlation found 
between male factor and euploidy rate or perinatal outcomes. 
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Burruel et al. (2014) investigated how the patterns of blastocyst formation was affected 
by oxidative damage to spermatozoa by evaluating the duration between the first 
mitosis and start of the second mitosis (P2) in embryo development. They used the 
rhesus macaque as an animal model. The results showed that less embryos with short 
P2 times (<1 hour) reached blastocysts, and nearly all of the embryos with longer P2 
times reached blastocysts by day 6 (P < 0.01). They also observed that duration of the 
second to third mitoses were sensitive cleavage phases when oxidative stressed 
spermatozoa were used. Embryos that had either too long or too short cytokinesis 
resulted in unsuccessful blastulation. Therefore, they suggested that paternal factors 
play a role in early mitosis, although paternal-derived genes are expressed during 
advanced embryo development. 
Lammers et al. (2015) investigated the effect of sperm origin, i.e. either freshly 
ejaculated or surgically (testicular and epididymal) retrieved spermatozoa, on embryo 
morphokinetic parameters during ICSI cycles. They also compared clinical outcomes 
and showed that these were comparable between the two different sperm sources. 
Early morphokinetic parameters were comparable between groups, but the t3, t8 and 
s2 parameters showed significant differences. They concluded that there was no 
difference in morphokinetic analysis between fresh ejaculated and surgically retrieved 
sperm, but stated that more studies are required with regards to relationship between 
sperm origin and late morphokinetic parameters such as blastocyst development. 
Desai et al. (2018) investigated the influence of spermatozoa sources on kinetic 
embryo development and clinical outcomes. The groups were divided into epididymal, 
testicular (obstructive and non-obstructive azoospermia diagnoses) and ejaculated 
normal spermatozoa. Results showed no difference in CPR between the three groups 
and a non-significant decline in implantation and birth rate of testicular spermatozoa 
compared to epididymal spermatozoa and the control group. They did see lower 
compacting embryo rates in non-obstructive testicular spermatozoa compared to the 
others, which is indicative of paternal activation (Desai et al., 2009). In the testicular 
sourced spermatozoa group, a significantly lower percentage of embryos showed 
kinetics typically attributed to high quality embryos. Their conclusion was that TL 
allows for greater comparison of paternal influence on embryo morphokinetics.  
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 Conclusion  
Specific morphokinetic events during embryo development after ART procedures have 
been used as markers for embryo selection, such as syngamy timing, to determine the 
viability and potential of successful embryo development and implantation 
(Mastenbroek et al., 2011, Wirka et al., 2014). Time lapse technology has added 
information leading to the development of algorithms (Fishel et al., 2018) to further 
improve the selection of embryos. However, patient diagnosis has not yet been taken 
into consideration in these algorithms. Neither the effect of male prognosis or the effect 
of syngamy timing on day 5 blastocyst development and quality have been elucidated.  
The role of spermatozoa and oocytes in syngamy, one of the key events during 
fertilization, and subsequent blastulation, which is a major predictive indicator of 
implantation, are still to be elucidated. This study aims to determine whether syngamy 
timing differs according to male patient prognosis and whether this in turn also affects 
the advanced embryo at blastocyst stage.  
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RESEARCH QUESTION  
Is there a relationship between syngamy timing, blastulation rate and blastocyst quality 
according to different male fertility prognosis groups in ART treated patients? 
HYPOTHESIS 
H0 (Null hypothesis) = There is no association between fertilization rate, syngamy 
timing, blastulation rate or blastocyst quality and male factor fertility prognosis.  
H1 (Alternative hypothesis) = There is an association between fertilization rate, 
syngamy timing, blastulation rate or blastocyst quality and male factor fertility 
prognosis. 
AIMS AND OBJECTIVES 
 Primary aim  
The primary aim of this study was to investigate the possible measurable direct effect 
of male fertility diagnosis on the time duration to the syngamy event when the 
spermatozoon contributes essential centrosomes during fertilization. 
 Secondary aim 
The secondary aim was to investigate the sequential effect of male fertility diagnosis 
on syngamy timing and resulting advanced embryo development when the paternal 
genome actively contributes to blastocyst formation and quality. 
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 Objectives  
• To identify and categorize treatment records into male prognosis groups 
according to diagnosis criteria: 
o Good prognosis, i.e. normal sperm diagnoses;  
o Sub-fertile prognosis, borderline diagnoses spermatozoa and  
o Severe sub-fertile prognosis, severe male factor diagnoses. 
• To calculate syngamy timings by using TL morphokinetic data points (tPNf - 
tPB2). 
• To determine the fertilization and blastulation rates of all the groups by using 
TL.  
• To determine and compare syngamy timing between the 3 male prognosis 
groups using TL.  
• To correlate overall syngamy timing with blastocyst quality parameters on day 
5 and also between the 3 male prognosis groups using TL.  
• To determine whether syngamy timing could contribute to day 5 blastocyst 
prediction and better embryo selection methods. 
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CHAPTER 2  
MATERIALS AND METHODS 
 Study design 
This was a retrospective study on embryo development records collected during 
standard embryo time-lapse evaluation after IVF and ICSI insemination treatment. No 
other interventions were performed. The study was completed over a period of two 
years, 2017 to 2018. 
Non-identifiable morphokinetic data of embryo development was extracted and sorted 
according to three defined male prognosis groups. The main parameter investigated 
and compared between the three male prognosis groups was syngamy timing. The 
secondary investigation focussed on both syngamy timing and subsequent blastocyst 
quality 116 to 125 hours post insemination, between the three male prognosis groups, 
as well as overall. 
 Study population 
All oocytes arising from patients who received any of the following ART procedures: 
IVF, ICSI, PICSI, and IMSI treatment from 2013 to 2016, at Wijnland Fertility Clinic in 
Stellenbosch, that were incubated in the time-lapse incubator, were included in the 
initial data set. All female diagnoses and age groups were included. Patient 
information was kept strictly confidential. 
The exclusion criteria are listed in the section (3) below. These criteria were 
specifically used in order to remove apparent major bias factors that could have had 
an impact on the outcomes of the study. 
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 Exclusion criteria 
The following exclusion criteria was applied to exclude irrelevant records to reduce 
statistical noise and possible confounding clinical patient factors. There also were 
records excluded due to unforeseen circumstances such as embryo developmental 
arrest. 
3.1 To reduce statistical noise  
Fertilization and initial data set phase: 
• Immature oocytes: Metaphase I (MI), germinal vesicle (GV) or atretic oocytes 
before insemination.  
Syngamy Timing calculation phase: 
• Zygotes with no or abnormal fertilization – 0PN, 1PN or ≥ 3PN or degenerative. 
Blastulation calculation and grading phases: 
• Zygotes with no or abnormal fertilization – 0PN, 1PN or ≥ 3PN or degenerative. 
• Zygotes not reaching either compact morula or blastocyst stage on day 5 of 
embryo development. 
3.2 To reduce possible additional confounding factors  
• Cancer patients with previous or current diagnosis due to possible unknown 
effects of cancer or cancer treatment on gametes. 
• Human Immunodeficiency Virus (HIV) or Sexually Transmitted Infections (STI) 
/ sero positive patients - due to very low numbers and the possible effects of 
infections and/or anti-retroviral medication on fertility, gametes and embryo 
development that have not been elucidated. 
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3.3 Inevitable exclusions due to unforeseen / unavoidable circumstances 
There is a natural drop-out trend of oocytes, zygotes and embryos in ART cycles due 
to developmental arrest. This was clearly observable in the sample size reduction from 
oocytes, to zygotes, to blastocyst development stage in this study. 
Records with any missing data points resulting from any of several reasons, for 
example human error or visual difficulty during annotation, were inevitably excluded. 
 Sample size  
The initial population size of N = 3103 mature oocytes were available in the raw data 
set. A total of 1292 oocytes had abnormal or failed fertilization and were excluded after 
fertilization rate calculation. The total number of normally fertilized (2PN) oocytes, that 
resulted in zygotes after fertilization, were 1811.  
After exclusion of 223 zygotes with missing tPNf and tPB2 data points, the final number 
of zygotes available for syngamy timing calculations, were n = 1588. 
A total number of n = 1262 embryos successfully reached compact morula stage from 
the 1811 normally fertilized zygotes. There were 1209 embryos that initiated blastocyst 
formation, with a tSB data point available to calculate blastulation rate. 
The number of embryos with day 5 development stage or expansion grade available 
for investigation were n = 1262 which included compact morulae (n = 53) and 
blastocysts (n = 1209). The number of expanded blastocysts with available 
trophectoderm and ICM scores were n = 857. 
 Division into male prognosis groups 
All males were included and categorized into three specific prognosis groups 
according to semen analysis diagnoses at the time of ART. The three male prognosis 
groups are specified as: good prognosis group (GP), poor prognosis group (PP) 
and very poor prognosis group (VP). Refer to Appendix A for Diagnoses definitions. 
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Good Prognosis group (GP) diagnosis criteria:  
Cases where either a) or b) were applicable: 
a) Normal concentration of ≥ 15 x106 per ml, and normal motility of ≥30% with 
either:  
o N-pattern morphology diagnosis - which is defined as a morphology 
result of greater or equal to 15% or, 
o G-pattern morphology diagnosis - which is defined as a morphology 
result of 5-14%.  
b) Donor sperm: 
o Sperm concentration ≥ 80 x 106 per ml, motility ≥ 50%, morphology ≥  
    8%, and/or, 
o Consideration of appealing demographic profile. 
 
Poor Prognosis group (PP) diagnosis criteria:  
Patients with a poor prognosis were either diagnosed with a) or b) or c): 
a) Normal sperm concentration of ≥ 15 x106 per ml, and normal motility of ≥30% 
with: 
o P-pattern morphology diagnosis - which is defined as a morphology 
result of 1-4%, also known as teratozoospermia or, 
o Borderline morphology diagnosis (GP-pattern) - which is a morphology 
pattern that falls into both the good and poor pattern categories (for 
example 4% and 5% morphology determined by two embryologists, 
respectively). 
b) Oligozoospermia (5 - 14 x106 per ml), irrespective of morphology diagnosis. 
c) Vasovasostomy aetiologies. 
Very Poor Prognosis group (VP) diagnosis criteria:  
Patients with a very poor prognosis were either diagnosed with a), b), c) or d): 
a) Astenozoospermia – characterized by semen samples with: 
o motility of less than 30% and / or, 
o forward progression of less than 2. 
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b) Severe oligozoospermia (<5 x106 per ml), irrespective of morphology diagnosis. 
c) Double or triple sperm defect diagnoses, where a combination of more than 
one abnormal sperm parameter is present, for example: oligo-asteno-
teratozoospermia (OAT). 
d) Azoospermia, including obstructive, non-obstructive, and vasectomy, where 
spermatozoa were retrieved via testis biopsy procedure. 
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 Data management 
Data for the project was acquired by exporting the data file that was automatically 
generated by the EmbryoScopeTM system during embryo annotation. The data of 
selected years (2013 to 2016) were exported into an excel spreadsheet (see Appendix 
C). 
The retrospective data was verified to reduce discrepancies and missing data points 
as far as possible. The records were then de-identified and aggregated to only collect 
the relevant medical diagnosis data and laboratory embryo annotations as the final 
dataset for analysis. It was subsequently filtered according to inclusion and exclusion 
criteria and finally divided into male prognosis groups as described. The applicable 
data columns required to perform the analyses and calculations were utilized, which 
included female age, female primary diagnosis, male diagnosis, tPNf, tPB2, PN status, 
start of blastocyst formation (tSB), and blastocyst quality (BQ) grade. 
The fertilization rate, syngamy timing, and blastulation rate were mathematically 
calculated. 
Patient diagnoses data was used for descriptive analysis of the sample size. The 
average female patient age was calculated per treatment cycle for each male 
prognosis group. 
The time duration to syngamy of the normally fertilized oocytes post insemination was 
calculated by subtracting the time of PN fading from the time of second polar body 
extrusion: Syngamy timing = tPNf – tPB2. The blastocyst formation rate was defined 
as the total number of blastocysts among the total normally fertilized (2PN) oocytes 
(Sepúlveda et al., 2011). Blastulation rate was calculated as a percentage value by 
dividing the number of early cavitating blastocysts (reached tSB) on day 5 of embryo 
culture by the total number of 2PN zygotes (normally fertilized oocytes): Blastulation 
rate = total embryos with tSB / total number of 2PN zygotes. 
Blastocyst quality (BQ) on day 5 was evaluated as described in the methodology 
section. Male fertility prognosis groups were correlated to syngamy timing, blastulation 
rate and BQ. 
Stellenbosch University  https://scholar.sun.ac.za
56 
 
 Assisted reproductive technology methods  
All patient diagnosis assessments and ART treatments were done according to the 
standard established practices of Wijnland Fertility Clinic. The assessment of female 
diagnosis was done by specialists at Wijnland Fertility Clinic according to established 
diagnostic criteria (see Appendix A). The ART treatment procedures which included 
controlled ovarian stimulation, oocyte retrieval, semen processing and in vitro 
fertilization were done according to standard operating procedures (SOP) of Wijnland 
Fertility Clinic (see Appendix G).  
The most relevant procedures to this study are discussed in more detail below. 
  Semen analysis and diagnosis 
The basic semen analysis entails parameters such as spermatozoa concentration, 
motility and morphology. This diagnostic test is done in advance to ART treatment and 
plays an important role in deciding on the specific ART treatment to follow. Therefore, 
the test may be repeated to achieve accurate results before final diagnosis and 
prognosis is established.  
Concentration and motility are determined by investigating a wet preparation slide of 
the semen sample. At least 10 fields are assessed to estimate concentration (x106 per 
ml) and motility (percentage). This is made by placing a drop of semen onto a glass 
slide with a glass cover slide over. The morphology parameter is determined by 
making a smear of the semen sample on a glass slide and staining it with Hemacolor® 
(MerckTM, South Africa), also known as the Diff-Quik method. The unmounted 
morphology slide was then examined under a light microscope under oil at 1000x 
times magnification and 100 spermatozoa are evaluated as either normal or abnormal 
based on the Tygerberg strict criteria (WHO, 2010). Morphology was also expressed 
as percentage.  
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The normal values for the following parameters were: concentration ≥ 15 x 106 per ml, 
motility ≥ 30%, forward progression >2 and morphology >4%. Diagnosis is based on 
these parameters, as well as other macroscopic parameters such as volume and pH. 
The male diagnosis for each patient was based on the sample parameters of the 
sample used on the day of the ART procedure. Definitions of diagnoses can be found 
in Appendix A and Wijnland Fertility Andrology reference values (see Appendix B).  
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 Time-lapse incubation equipment: EmbryoScopeTM 
9.1 Time-lapse EmbryoScopeTM incubator 
The EmbryoScopeTM incubator is designed to provide optimal culture condition as well 
as embryo monitoring and annotation (See Fig 2.1). All electronic components are 
kept in a separate compartment ensuring no embryo exposure to electric fields during 
culturing and incubation. 
The incubator allows embryo culturing in small individual wells and has improved 
carbon dioxide (CO2) and oxygen (O2) recovery rates compared to bench-top 
incubators. 
The incubators have a tri-gas system and gases are re-circulated through a HEPA and 
carbon filter to minimize volatile organic compounds and other particles. Temperature 
of the EmbryoScopeTM incubator is kept constant and the heat foil inlay heating system 
is mounted within the slide holder core. Vitrolife performed temperature experiments 
and concluded that each micro-well differed approximately 0.2°C from the heated core. 
Therefore, temperature of the heated core should be about 37.2°C in order to achieve 
37.0°C. 
Time-lapse EmbryoScopeTM incubators are not humidified and require oil-overlaid 
culturing. Non-humidified incubation has some benefits which include minimizing 
contamination of fungal growth, airborne particles and pathogens. Oil-overlay 
promotes minimizing microenvironment fluctuations, by delaying gas diffusion and 
evaporation. Vitrolife also performed experiments on osmolality after 5 days of 
culturing and established that the osmolality of the media is within the range for human 
embryo culture. If any changes in pH occur, oil will increase equilibration time. Imaging 
in the EmbryoScopeTM is acquired by using a single red LED (635nm). Light exposure 
is controlled by built-in monitors, ensuring that defined limits are not exceeded.  
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Figure 2.1. The EmbryoScopeTM Time-Lapse system with incubator and Software.  
Image sources from Vitrolife Technotes: https://www.vitrolife.com/globalassets/support-
documents/tech-notes/technote_safety-of-incubation-in-the-embryoscope-time-lapse-system.pdf 
9.2 Time-lapse embryo culture dish 
EmbryoSlide® culture dishes are specifically designed for the EmbryoScopeTM time-
lapse incubators to ensure safe handling, accommodate single embryo culture and 
allow accurate and high-quality microscopy imaging of each embryo. Each 
EmbryoSlide® is produced from culture-tested polystyrene and has 12 microwells that 
allow for culturing of up to 12 embryos, as well as 4 wash wells. EmbryoSlide® culture 
dishes were prepared either on the day before embryo culture and equilibrated 
overnight or on the day of use and pre-equilibrated ≥4 hours before embryos are 
incubated for culturing. EmbryoSlides® were prepared with cold universal embryo 
culture medium and oil, on a non-heated workbench. Each microwell was filled with a 
small amount of medium to create a meniscus, thereafter filled completely with 25ul of 
medium and approximately 1.4ml of oil is then overlaid (see Appendix G). Bubbles 
which may have formed after equilibration of ≥4 hours are removed with a micropipette 
(see Appendix G).  
After insemination, oocytes were placed in the EmbryoSlide® to be cultured in the 
EmbryoScopeTM incubator for 6 days and annotations were made during this period.  
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 Embryo annotation and syngamy 
Each patient’s embryos were labelled on the system with patient information which 
included female age, diagnosis, and case number for accurate matching of patients to 
their embryos. Each embryo culture slide was then also automatically allocated a 
unique embryo slide identifier and an embryo identification number which was stored 
in the background by the system. These identifiers were used to distinguish between 
treatment cases and individual embryos.  The embryos were not for embryo evaluation 
as all annotations and grading was done through the EmbryoScopeTM image capturing 
software. The EmbryoScopeTM ensures non-invasive evaluation and selection of the 
embryos.  
The time-lapse incubator (EmbryoScopeTM) records images of each embryo at 15-
minute intervals. Zygote and embryo development were annotated daily by 
embryologists at certain embryo development stages. Specific fertilization annotations 
include time of second polar body extrusion (tPB2), the time of PN appearance (tPNa), 
the confirmed number of PN’s visible at 17 to 18hours (fertilization status), and time of 
PN disappearance (tPNf). Subsequent timings of embryo cell cleavages were also 
annotated (t2-t8) until 9-cell stage (on day 3 of embryo development). Advanced 
embryo developmental stages, such as morulation (tM) and blastulation was 
annotated from day 4 onwards, which included start of blastulation (tSB), full 
blastulation (tB), blastocyst expansion (tEB), hatching (tHB) and the final blastocyst 
grade. Vitrolife provides a detailed guideline of Time-lapse annotations and timings 
(see Appendix G).  
 Embryo evaluation – specifically blastocyst stage grading  
Blastocyst evaluation for morphology grading was followed using the SOP of Wijnland 
Fertility Clinic (see Appendix G). Blastocyst scoring was done using a modified 
Gardner score in combination with the Vitrolife blastocyst scoring guidelines for the 
EmbryoScopeTM (see Appendix G). These evaluations are based on the expansion of 
the blastocyst (scored 1-6), the inner cell mass (scored A-C) and trophectoderm 
epithelium (scored A-C). An A-grade ICM and TE is the best score and C-grade is 
subsequently the lowest. 
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The timing annotations and final blastocyst scores allow embryologists to select 
embryos for transfer, cryopreservation or rejection accordingly. The system also 
enables the exportation of the captured electronic data which contains every embryo’s 
data points from the annotations and the embryo grading scores. 
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 Flow diagram of data management 
 
 
 
 
Figure 2.2. Flow diagram of data management and processing. Phase 1 = Database filtering;        
Phase 2 = Correlate and compare syngamy time and blastulation. 
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 Limitations 
One maternal factor limitation of this study is the heterogeneity of the female 
population. This was due to the fact that no female factor was excluded in order to 
ensure a powered sample size. Therefore, the maternal effect, apart from female age, 
which was compensated for, could not be excluded.  
Sperm morphology is a subjective evaluation parameter; however, the reliability of this 
result is usually internally validated by peer-assessment. Internally, usually more than 
100 spermatozoa are counted by more than one technician, although there is a 
possible discrepancy that can occur within laboratories. Therefore, external quality 
control is implemented to uphold benchmark standards. However, in this study 
morphology was only internally controlled and therefore borderline results remained in 
the dataset, with the lower morphology used as indicator for prognosis group 
categorization.  
Blastocyst grading is also a subjective interpretation by embryologists (scientists and 
technologists) and therefore may affect consistency (reliability) of blastocyst gradings. 
However, the data set in this study contained data points that were evaluated by more 
than one embryologist at the time of annotation or grading (double witness system). 
IVF and ICSI insemination methods were both included. IVF sperm selection is based 
on natural sperm-oocyte binding interaction. ICSI is designed to compensate for poor 
male prognosis sperm and sperm selection is based on embryologist subjectivity  
 Ethical considerations 
Ethical approval was obtained prior to study initiation for the period of: 09 February 
2018 until 08 February 2019 for Project ID: 0751, HREC Reference: S17/08/158 (see 
Appendix F). 
Due to the retrospective nature of the study, patients were not subjected to any 
additional risks, injury or pain. Data was anonymized and aggregated during 
importation into the work sheet for analysis, ensuring no patient identity was revealed, 
and remained confidential. The data was analysed in groups, ensuring that data was 
not analysed individually. The research was done to produce valuable information that 
likely could improve embryo selection and patient treatment in future.  
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The Health Research Ethics Committee kindly waived informed consent when the 
protocol was submitted for ethical approval.  
 Statistical analysis  
A statistician from Stellenbosch University was consulted for appropriate statistical 
analysis and results.  
For comparisons of the different diagnoses between groups, cross tabulation with the 
Chi-square test were done. Continuous variables like syngamy timing were compared 
between groups using mixed model ANOVA. In these analyses group and female age 
(covariate) were treated as fixed effects, and patients as random effect. Binary 
outcomes (e.g. fertilization) were compared between groups using generalized 
estimating equations (GEE) with the Binomial as underlying distribution. Age was 
included as covariate. For post hoc testing, Fisher Least Significant Difference (LSD) 
was used. The significance level of 5% (P <0.05) was used as guideline for 
determining statistically significant results. 
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CHAPTER 3  
RESULTS 
The results of the study are presented in Figures 3.1-3.13 and Tables 3.1-3.10. 
 Descriptive results of sample size  
The PP group constituted the majority of the total sample size (n = 1588), consisting 
of 46.9% with 746 zygote records. The GP group consisted of 537 zygotes, which was 
33.8% of the total sample size. The VP group had 305 zygotes and consisted of 19.2% 
of the total sample size (see Table 3.1). 
The majority of the GP group zygotes had a paternal diagnosis of normozoospermia 
(90.7%) and the PP group mostly teratozoospermia (87.5%). The VP group mainly 
had non-obstructive testis biopsy diagnoses (21.3%) and oligoastenosoospermia 
(18.0%). The remainder of diagnoses in each group is further described in Table 3.1 
and Figure 3.1. 
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Table 3.1. Descriptive table depicting the frequencies and percentage distribution of male diagnoses, 
overall and in each male prognosis group, which had normal (2PN) fertilization and available syngamy 
timings. 
GOOD PROGNOSIS (GP) GROUP N PERCENTAGE (%) 
Donor sperm 50 9.3 
Normozoospermia 487 90.7 
Total 537 33.8 
POOR PROGNOSIS (PP) GROUP N PERCENTAGE (%) 
Teratozoospermia 653 87.5 
Oligozoospermia  40 5.4 
Borderline Morphology  15 2.0 
Oligo-teratozoospermia 36 4.8 
Vasovasostomy 2 0.3 
Total 746 46.9 
VERY POOR PROGNOSIS (VP) GROUP N PERCENTAGE (%) 
Severe Oligozoospermia  26 8.5 
Asthenozoospermia 34 11.1 
Astheno-teratozoospermia 21 6.9 
Oligo-asthenozoospermia 55 18.0 
Severe Oligo-asthenozoospermia 26 8.5 
Severe Oligo-teratozoospermia 11 3.6 
Oligo-astheno-teratozoospermia 45 14.8 
Testis Biopsy – Non-obstructive 65 21.3 
Testis Biopsy -Obstructive 11 3.6 
Testis Biopsy – Post Vasectomy 11 3.6 
Total 305 19.2 
Grand Total 1588 100 
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Figure 3.1. A categorized histogram depicting the distribution of male diagnoses within each male 
prognosis group. 
The most frequent female diagnosis, from which oocytes were retrieved across all 
three male prognosis groups was Idiopathic / No female factor indicated, comprising 
of 30.2% in the GP group, 46.8% in the PP group and 48.9% in the VP group (see 
Table 3.2).  
The remainder of the primary female oocyte diagnoses are further described in Table 
3.2 and Figure 3.2.  
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Table 3.2. Descriptive table depicting with frequencies of oocyte records and percentages of all 
female oocyte diagnoses, in each male prognosis group, which had normal (2PN) fertilization and 
available syngamy timings. 
Male Prognosis 
 Groups 
 GP Group PP Group VP Group 
Primary Female 
Oocyte Diagnosis 
N  
(oocyte 
records) 
% 
N 
(oocyte 
records) 
% 
N 
(oocyte 
records) 
% 
Advanced Maternal 
Age 
91 16.9 182 24.4 59 19.3 
Anovulation 6 1.1 9 1.2 0 - 
Donor Oocytes 145 27.0 55 7.4 42 13.8 
Endometriosis 14 2.6 13 1.7 2 0.7 
Idiopathic / No female 
factor indicated 
162 30.2 349 46.8 149 48.9 
Oligomenorrhea 3 0.6 0 - 0 - 
PCO/PCOS 30 5.6 78 10.5 7 2.3 
Poor Ovarian Reserve 10 1.9 16 2.1 25 8.2 
Premature Ovarian 
Failure 
6 1.1 18 2.4 1 0.3 
Recurrent Miscarriage 6 1.1 2 0.3 17 5.6 
Same-sex couples / 
Single Female 
0 - 6 0.8 0 - 
Tubal Factor 64 11.9 18 2.4 3 1.0 
Totals 537 746 305 
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The distribution of zygote female diagnoses between the male prognosis groups were 
significantly different (P < 0.01), as depicted in Figure 3.2.  
 
Figure 3.2. A categorized histogram depicting the distribution of primary female diagnoses of each 
zygote record within and between the three male prognosis group i.e. GP, VP and PP. 
A two-way summary table of the chi-square analysis of the female diagnoses between 
the male prognosis groups is available in Appendix D.  
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The mean female patient age per treatment cycle in the GP group was 34.7 ± 6.31 
years, the PP group age was 35.73 ± 5.16 years and the VP group age equal to 34.05 
± 5.65 years. The GP consisted of 112, the PP group of 172 and the VP group of 74 
treatment cycles (see Table 3.3).  
Table 3.3. Descriptive table of number of patient cycles, mean female patient age (years) per treatment 
cycle, and standard deviation overall and of each male prognosis group. 
Group 
N 
(Patient cycles) 
Mean Female Patient 
Age (years) 
Age 
Standard Deviation 
GP 112 34.70 6.31 
PP 172 35.73 5.16 
VP 74 34.05 5.65 
Total 358 35.06 5.67 
 
There was no significant difference in the mean average female age per treatment 
cycle between the male prognosis groups (P = 0.12) (see Fig 3.3). Post hoc analysis 
results showed a significant difference in mean female patient age in the PP group 
compared to the VP (P = 0.03). Mean female patient age per treatment cycle was not 
significantly different between the GP and PP (P = 0.13) groups or between the GP 
and VP groups (P = 0.45). 
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Figure 3.3. A Least-squares means (LS means) plot depicting the average (mean) female patient age 
(years) per treatment cycle in the three male prognosis groups (a vs b = P < 0.05). 
 Fertilization 
In total, the database consisted of 3103 oocyte records before undergoing filtering 
(see Table 3.4). In the GP group (n = 1043 records) there were 416 abnormally or non-
fertilized oocytes and 627 normally fertilized oocytes. The normal fertilization rate for 
the GP group was 60.12%. In the PP group (n = 1443 records) 594 oocytes fertilized 
abnormally or not at all and 849 oocytes fertilized normally. The normal fertilization 
rate in the PP group was 58.84%. In the VP group (n = 617 records) there were 282 
abnormally or non-fertilized oocytes and 335 normally fertilized oocytes. The normal 
fertilization rate in the VP group was 54.29%. The total normal fertilization rate for all 
three groups combined was equal to 58.36% (1811/3103). 
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Table 3.4. Summary of the number of normally and abnormally fertilized oocytes, sample sizes and 
fertilization rates overall and of each male prognosis group. 
Groups 
Failed or 
Abnormally 
Fertilized 
Oocytes 
Normally 
Fertilized 
Oocytes 
Totals 
Fertilization 
Rate 
GP 416 627 1043 60.12% 
PP 594 849 1443 58.84% 
VP 282 335 617 54.29% 
Totals 1292 1811 3103 58.36% 
*Fertilization rate (%): number of normally fertilized oocytes divided by the total number of oocytes 
inseminated. 
 
There was no significant difference in the normal fertilization rate between the male 
prognosis groups (GP, PP, VP) (P = 0.19) (see Figure 3.4). Post-hoc test results 
showed no significant differences in normal fertilization rate between the GP and PP 
groups (P = 0.75); the GP and VP groups (P = 0.14) or the PP and VP groups (P = 
0.08). Although it seemed that the VP group had a lower fertilization rate compared to 
the other groups, the result did not reach statistical significance. Therefore, all three 
groups had the same chance for normal fertilization. 
 
 
Figure 3.4. Graph depicting the GEE results of the probability of each male prognosis group (GP, PP, 
VP) to successfully fertilize an oocyte normally (2PN). 
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Neither female age (P = 0.52) nor male prognosis (P = 0.19) showed any effect on 
fertilization rate (P = 0.19) (see Table 3.5).  
Table 3.5. Table depicting the Wald parametric test results, showing the effect of female age and male 
prognosis group on the chances of normal fertilization. 
Effect Df Wald P. value 
Age 1 0.40 0.52 
Group 2 3.31 0.19 
 Syngamy timing (hours) 
Different statistical tests were used to analyse the effect of male prognosis group on 
syngamy timing.  
The overall median syngamy timing was 19.60 hrs, with a mean of 20.16 hrs and 
standard deviation (sd) of 4.1 hrs. The minimum equalled 0.3 hrs and maximum 55.4 
hrs. The 25th percentile was at 17.5 hrs and 75th percentile at 22.1 hrs (see Figure 
3.5). 
 
Figure 3.5. Histogram depicting frequency of observed syngamy timings (hrs) across all records, 
median, mean, minimum, maximum and outliers. 
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The GP group had a mean syngamy timing of 19.73 hrs ± 3.69 hrs. The PP group had 
a mean syngamy timing of 20.21 hrs ± 4.14 hrs. The VP group had a mean syngamy 
timing of 20.80 hrs ± 4.71 hrs. The overall mean syngamy timing of the three male 
prognosis groups were 20.16 ± 4.13 hrs (see Table 3.6).  
Table 3.6. Table showing descriptive statistics of the mean syngamy timings (hrs) and standard 
deviations overall and of each male prognosis group. 
Groups N 
Mean Syngamy 
Timing 
Standard Deviations 
GP 537 19.73 3.69 
PP 746 20.21 4.14 
VP 305 20.80 4.71 
Totals 1558 20.16 4.13 
The mean difference in syngamy timing between the GP and PP groups were 0.47 hrs 
(P = 0.23); between the GP and VP groups were 1.06 hrs (P = 0.02) and between the 
PP and VP groups were 0.58 hrs (P = 0.16). Covariates such as female age and male 
prognosis group were accounted for. The only significant difference in syngamy 
timings were between the GP and VP groups (P = 0.02). Patients in the VP group 
therefore had a significantly longer syngamy timing in comparison to the GP group 
(see Table 3.7).  
Table 3.7. Least Significant Difference test outcome of the comparison between the three male 
prognosis groups with regards to syngamy timings(hrs)  
Group 1 Group 2 
Mean Syngamy 
Timing 
Difference 
Standard Error P. value 
GP PP -0.47 0.39 0.23 
GP VP -1.06 0.46 0.02 
PP VP -0.58 0.42 0.16 
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The overall P-value calculated was equal to 0.07, showing no significant difference 
between male prognosis groups. Post hoc analysis showed a significant difference 
between the syngamy timings of the GP and VP groups (P = 0.02) (see Figure 3.6).  
 
Figure 3.6. A Least-squares means (LS means) plot depicting the mean syngamy timings and the 95% 
confidence intervals for all three male prognosis groups (a vs b = P < 0.05). 
The confounding effects of female age and male prognosis group on the syngamy 
timings were tested and showed that female age had a significant effect on syngamy 
timing (P = 0.02). Overall male prognosis group, had no significant effect on syngamy 
timing (P = 0.07) (see Table 3.8). 
Table 3.8. Summary of the fixed effect test result of female age and different male diagnosis groups on 
syngamy timing. 
Effect *Num. DF *Den. DF *F  P. value 
Age 1 1314 5.63 0.02 
Group 2 1314 2.66 0.07 
(*Num. DF = Degrees of freedom of the numerator, Den DF = Degrees of freedom of the denominator, F = 
Variation Between Sample Means / Variation Within the Samples.) 
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 Blastulation 
The total number of blastocysts for all three groups were equal to n = 1209. The overall 
blastulation rate was 66.67% (1209/1811). In the GP group, 406 embryos reached 
initiation of blastulation, with a blastulation rate of 64.75% (406/627). The PP group 
had 591 embryos that reached initiation of blastocyst stage with a blastulation rate of 
69.61% (591/849), while the VP group had 212 embryos that reached initiation of 
blastocyst stage with a blastulation rate of 63.28% (212/335) (see Table 3.9). 
Table 3.9. Summary of the number of normally fertilized oocytes which either failed to reach blastocyst 
stage or successfully reach blastocyst stage. Blastulation rates of male prognosis groups and overall 
rate is shown. 
Group 
Blastulation 
Failure 
Blastulation 
Reached 
Totals Blastulation Rate 
GP 221 406 627 64.75% 
PP 258 591 849 69.61% 
VP 123 212 335 63.28% 
Totals 602 1209 1811 66.76% 
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The GEE results for the probability of normally fertilized oocytes –in each male 
prognosis group – to successfully reach blastulation had a P-value calculated equal to 
0.25. Therefore, male prognosis group had no significant effect on blastulation rate 
overall. The post-hoc test also showed no significant differences in reaching 
blastulation between the three male prognosis groups (see Figure 3.7). 
 
Figure 3.7. Graph depicting the GEE outcome for the probability of normally fertilized oocyte to reach 
blastulation in each male prognosis group. 
Two factors, female age and male prognosis group and their confounding effects on 
blastulation were tested using the fixed effect test. Female age was shown to have a 
significant effect on blastulation rate (P < 0.01). However, male prognosis group 
showed no significant effect on blastulation rate (P = 0.25) (see Table 3.10). 
Table 3.10. Summary of the Wald parametric test of female age and different male diagnosis groups 
on blastulation rate. 
Effect Degrees of freedom Wald P. value 
Age 1 8.05 0.00 
Group 2 2.77 0.25 
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 Effect of syngamy timing on blastocyst grading 
5.1 Blastocyst expansion and syngamy timing 
Blastocyst expansion was significantly associated with shorter syngamy timing as the 
overall P-value was significant (P < 0.01) (see Figure 3.8). 
Post-hoc analysis showed significant differences between specific blastocyst 
expansion grades and syngamy timing.  
Early blastocysts (EB) showed a significantly shorter syngamy timing compared to 
compact morulae (CM) (P = 0.04), but showed no difference compared to grade 1 
expanded blastocysts. Grade 1 expanded blastocysts showed similar syngamy 
timings in comparison to grade 2 or grade 3 expansions. However, grade 1 expanded 
blastocysts did show shorter syngamy timing compared to CM (P = 0.02). Syngamy 
timing of grade 2 expanded blastocysts significantly differed from CM (P < 0.01), EB 
(P = 0.01) and grade 4 expansion (P = 0.02). Grade 2, grade 3 and grade 5 expansions 
showed similar syngamy timings. Grade 3 blastocyst expansion showed significantly 
shorter syngamy timing compared to CM (P < 0.01), EB (P < 0.01) and grade 4 
expansion (P < 0.01), but did not show any difference compared to grade 5 expansion. 
Grade 4 blastocyst expansion had significantly shorter syngamy timings compared to 
most other blastocyst expansion grades: CM (P < 0.01), EB (P < 0.01), grade 1 (P < 
0.01), grade 2 (P = 0.02), and grade 3 (P < 0.01). There was no difference in syngamy 
timing between grade 4 and grade 5 expansions. Grade 5 blastocyst expansion 
showed significantly shorter syngamy timing compared to CM (P < 0.01), EB (P = 0.01) 
and grade 1 (P = 0.05). The complete LSD test table of expansion and syngamy timing 
is available in Appendix E. 
Covariates such as female age, male prognosis group and the inter-effect between 
grade and group were included in the analysis. The post hoc results for female age 
showed no significant effect on blastocyst expansion (P = 0.16). The inter-effect 
between grade of expansion and male prognosis group also showed no significant 
effect (P = 0.71). 
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Figure 3.8. A Least-squares means (LS means) plot showing overall syngamy timing versus the degree 
of blastocyst expansion on day 5 (a vs. b vs. c vs. d vs. e = P < 0.05). 
The better grade of blastocyst expansion was associated with shorter syngamy timings 
in all three male prognosis groups (see Figure 3.9). Results showed no significant 
difference between the three groups with regard to blastocyst expansion and syngamy 
timings (P = 0.80). The post-hoc tests showed no significant difference between the 
GP and PP groups (P = 0.09), also not between GP and VP groups (P = 0.62) and 
neither between the PP and VP groups (P = 0.52). 
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Figure 3.9. A Least-squares means (LS means) plot showing syngamy timings(hrs) versus day 5 
blastocyst expansion grade for all three male prognosis groups. 
5.2 Blastocyst ICM grading and syngamy timing  
There was no significant overall effect of syngamy timings on blastocyst ICM grade on 
day 5 of embryo culture (P = 0.36) (see Figure 3.10). Post hoc analysis also indicated 
no significant syngamy timing effect between ICM A and B grading (P = 0.22); ICM A 
and C grading (P = 0.26) and ICM B and C grade (P = 0.09). Female age and male 
prognosis groups also had no significant effect (P = 0.19 and P = 0.62, respectively). 
The inter-effect between male prognosis groups and grade of ICM was also not 
significant (P = 0.15).  
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Figure 3.10. A Least-squares means (LS means) plot of overall syngamy timing (hrs) versus Inner Cell 
Mass (ICM) grade of day 5 of blastocyst. 
There was no significant overall effect of syngamy timings on ICM grade of day 5 
blastocysts between the three male prognosis groups (P = 0.62) (see Figure 3.11). All 
post hoc analysis results were also not significant (P ≥ 0.06) for: Grade A ICM in the 
GP group in comparison to grade C ICM in the GP group (P = 0.06); grade A ICM in 
the GP group compared to grade B ICM in the VP group (P = 0.06) and grade A ICM 
in the GP group compared to grade A ICM in the PP group (P = 0.07). 
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Figure 3.11. A Least-squares means (LS means) plot showing syngamy timings(hrs) versus Inner Cell 
Mass (ICM) grading of day 5 blastocysts for all three male prognosis groups.  
5.3 Blastocyst TE grading and syngamy timing 
There was no significant overall effect of syngamy timings on blastocyst 
trophectoderm grade on day 5 of embryo culture (P = 0.07) (see Figure 3.12). 
However, post hoc analysis indicated a significant syngamy timing effect between 
blastocyst trophectoderm A and B grades (P = 0.02). Grade A blastocyst 
trophectoderm had a significantly shorter syngamy timing compared to grade B 
blastocyst trophectoderm gradings. However, post hoc analysis showed no significant 
effect of syngamy timing on grade B versus grade C trophectoderm (P = 0.37) or grade 
A trophectoderm versus grade C trophectoderm (P = 0.26) blastocyst gradings.  
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Figure 3.12. A Least-square means (LS means) plot showing overall syngamy timing(hrs) versus day 
5 blastocyst trophectoderm grade. (a vs b = P < 0.05). 
Although syngamy timing seemed to be shorter in blastocysts with better 
trophectoderm grading, the result did not reach statistical significance. There was no 
significant overall effect of syngamy timings on day 5 blastocyst trophectoderm grades 
or between the three male prognosis groups (P = 0.31) (see Figure 3.13). However, 
post hoc analysis results showed a significantly shorter syngamy timing in the GP 
group with A grade trophectoderm grading versus the VP group with B grade 
trophectoderm grading (P = 0.05). In the VP group, Grade A trophectoderm 
blastocysts also had a significantly shorter syngamy timing compared to grade B 
trophectoderm blastocysts (P = 0.04).  
Stellenbosch University  https://scholar.sun.ac.za
84 
 
 
Figure 3.13. A Least-squares means (LS means) plot showing syngamy timings versus day 5 blastocyst 
trophectoderm grading for all three male prognosis groups. 
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CHAPTER 4  
DISCUSSION 
ART success and treatment outcome is highly dependent on embryo selection for 
embryo transfer, especially in SET laboratory settings. Research is ongoing to identify 
strong predictive markers, specifically non-invasive, observable and/or measurable 
embryo developmental markers, for implantation and ultimately successful live birth. 
Human embryo culture in CO2 incubators has advanced to being equipped with TL 
technology and software. This enables embryologists to study and incorporate many 
different embryo developmental traits during an uninterrupted and undisturbed embryo 
culture environment for blastocyst quality prediction and embryo selection. The 
predictive value of many of these embryo morphokinetic characteristics is still 
controversial, as the repeatability is limited in different laboratory settings, besides 
from large trials (Meseguer et al., 2012, Basile et al., 2014b). The effects of patient 
diagnoses and other factors on these events have also not yet been established and 
large studies like that of Meseguer et al. (2012) included mainly oocyte donation 
patient populations. 
In this TL study, one of the early fertilization developmental events, syngamy, was 
specifically investigated in relation to male factor prognosis. Sperm quality and 
syngamy are most probably highly interconnected due to the contribution of the 
functional spermatozoan centrosome (Wirka et al., 2014) and also the sperm DNA 
quality affecting EGA (Castillo et al., 2018) and thus blastulation (Desai et al., 2009). 
The time duration to syngamy, as well as the effect of male factor infertility on syngamy 
timing were investigated to elucidate the possible paternal effect/contribution of the 
functional centrosome.  
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Our study also aimed to investigate subsequent advanced embryo developmental 
traits during blastulation, in relation to initial syngamy time and male prognosis. In 
advanced stages of embryo development, the spermatozoon plays a significant role 
during EGA and contributes to blastulation. Therefore, the effect of syngamy time on 
day 5 embryo development was specifically investigated by evaluating the blastocyst 
quality with regards to blastocoel expansion size, inner cell mass quality and 
trophectoderm quality. The effect of the three different male prognosis groups on 
day 5 embryo development (blastocyst stage) was also investigated. 
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 Descriptive Data 
The distribution of normally fertilized zygotes across female diagnoses between the 
three male prognosis groups were significantly different in this study. The main female 
diagnosis in all three male prognosis groups and overall, was idiopathic. Idiopathic 
diagnosis was defined according to the primary female diagnosis of each oocyte 
record, regardless of the male diagnosis result. The high prevalence of idiopathic 
female diagnoses for the recorded and analysed oocyte data in the GP male prognosis 
group (30.2%) agrees with literature stating that 8% to 40% of female patients has 
idiopathic diagnoses (Ray et al., 2012, Gelbaya et al., 2014, Abdelazim et al., 2018). 
However, the PP and VP male prognosis groups had a higher prevalence of idiopathic 
oocyte records (46.8% and 48.9%). This could be attributed to the fact that these two 
male prognosis groups had a definitive male infertility factor indication, which was not 
included as a primary female oocyte diagnosis, but rather indicated as idiopathic 
diagnosis. Therefore, these records were automatically categorized into the idiopathic 
infertility diagnosis, increasing the number of oocyte records. 
The GP group also had a relatively high prevalence of donor oocytes, which indicates 
that there were female infertility factors in this group that played a role and increased 
donor oocyte ART treatment in this group.  
The female study population was very heterogeneous amongst and across male 
prognosis groups and was one of the study limitations. 
The second highest prevalence in both the PP and VP groups was advanced maternal 
age, a factor well known to have an impact on ART according to the literature (Lawler 
et al., 2007, Liu et al., 2011). Female age between the three male prognosis groups 
was calculated and analysed per treatment cycle, which showed no overall significant 
difference. This minimized the possible confounding effect that female oocyte age 
could have had on the results. However, there was an increased female age in the PP 
group in comparison to the VP group, which could be expected when taking into 
account that the PP group’s second highest female oocyte diagnosis was advanced 
maternal age. Female age was compensated for in this study as a covariate by 
statistical analysis. 
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The primary outcome of this study was to investigate the three male prognosis 
groups, thus female diagnosis was not compensated for. Study population size would 
have been reduced dramatically if only donor oocytes were included and therefore all 
female diagnoses were included, also giving a more realistic representation of the 
populations that clinics observe every day. 
The male diagnoses were intentionally categorized according to prognosis groups and 
therefore it was expected that the diagnosis distribution of the three male prognosis 
groups would be very different. The different male diagnoses within the poor prognosis 
groups were not evenly distributed, where teratozoospermia was the major diagnosis 
in the PP group (87%), and non-obstructive azoospermia (21%) and oligo-
asthenozoospermia (18%) was the majority in the VP group. 
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 Fertilization  
The overall fertilization rate (58.36%) of the three male prognosis groups was not 
statistically significant. Therefore, all three male prognosis groups (GP: 60.12%; PP: 
58.84% and VP: 54.29%) had the same chance to normally fertilize an oocyte. 
This agrees with a study by Yerebasmaz et al. (2017) who showed no significant 
difference in the fertilization rate of a male factor study group (50.8%) in comparison 
to the control group (51.2%). Borges Jr et al. (2017) also showed no significant 
difference in normal fertilization rates between male factor (75.72 ± 20.50%) and tubal 
factor (78.42 ± 18.36%) groups. Lammers et al. (2015) reported no significant 
difference in fertilization rate between the origin of spermatozoa samples in ejaculated 
spermatozoa (61.00%) compared to surgically removed spermatozoa (48.48%). 
Post hoc analysis results showed there was no significant difference between the 
fertilization rates of the GP and PP male prognosis groups or the GP and VP male 
prognosis groups. The fertilization rate was slightly higher for the GP group compared 
to the PP and VP groups. The PP group had a slightly lower fertilization rate compared 
to the GP group and the VP group. The VP group had the lowest fertilization rate 
compared to both the GP and PP groups and the difference between the VP and PP 
group showed a significant difference at the 90% confidence interval. 
This finding of an observable decreasing trend in fertilization rate from the GP to PP 
to VP groups, although not statistically significant, was also reported in other studies 
in literature where poorer male diagnoses had lower fertilization rates. Hourvitz et al. 
(1998) showed a lower fertilization rate in non-obstructive azoospermia or oligo-
astheno-teratozoospermia (42%), compared to the control group of ejaculated 
spermatozoa (55.5%). Verza Jr and Esteves (2008) showed a lower fertilization rate 
in triple defect spermatozoa (63.4 ± 25.9%) and testicular retrieved sperm from non-
obstructive azoospermia patients (52.2 ± 29.3%) in comparison to other diagnoses 
(~73%). Another study by Zheng et al. (2016) also reported lower fertilization ability as 
the motility of severe oligozoospermia patients declined in male groups. 
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ICSI is the method of choice applied for treatment of poor male prognosis. The overall 
similar fertilization rate results across male prognosis groups in the current study could 
be explained based on the fact that ICSI selects the best possible sperm cell based 
on motility and morphology, although not necessarily selecting for normal genetic and 
epigenetic spermatozoa profiles (Denomme et al., 2018). ICSI could therefore possibly 
compensate for poor male prognosis to a certain extent. The similar fertilization rate 
trend observed in the current study for the different male prognosis groups, could 
therefore be expected. 
The possible confounding factor, female age, showed no statistical significant effect 
on normal fertilization rate. This indicates that all three male prognosis groups had the 
same probability for normal fertilization and female age did not affect normal 
fertilization chances. Normal fertilization rates were similar irrespective of male 
prognosis group or female age. 
This finding agrees with other studies in literature. Grøndahl et al. (2017) showed that 
female age had no effect on the normal fertilization rate of zygotes, but that patients 
with advanced maternal age had an increased abnormally fertilized zygotes in IVF and 
ICSI cycles. Borges Jr et al. (2017) showed in women older than 35 years, the normal 
fertilization rates between the male factor (73.98 ± 22.33%) and tubal factor (77.83 ± 
18.40%) groups had no significant difference. They also reported no significant 
difference in normal fertilization rates between male factor (76.41 ± 19.71%) and tubal 
factor (78.78 ± 18.41%) groups in women younger than 35. 
In this study we included different insemination methods: IVF, ICSI and variations of 
ICSI insemination methods (PICSI and IMSI).  
Literature reports on ART outcomes in different insemination methods are very 
controversial. Plachot et al. (2002) reported no significant difference in the fertilization 
rate, embryo morphology or development, pregnancy and implantation rates between 
ICSI and IVF patients with male factor infertility. Yoeli et al. (2008) showed higher 
fertilization rates in ICSI than in IVF (67.1% vs 43.6%), but no significant difference in 
the embryo quality. A meta-analysis by Johnson et al. (2013) showed that ICSI had 
better fertilization rates and a smaller risk for total fertilization failure compared to 
conventional IVF in couples with unexplained infertility. 
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In this study, ICSI was mostly indicated and applied in male factor infertility cases or 
in patients where female factors such as advanced maternal age was indicated as a 
treatment decision. The inclusion of all insemination methods is stated as a limitation 
of the study in the methods section. 
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 Syngamy Timing 
Syngamy timing and the calculation thereof are defined differently in reports in 
literature, with no consensus on how syngamy should be determined and/or defined. 
Many studies used time of insemination as the reference point (t0), which does not 
allow an accurate and consistent starting point, as each oocyte insemination time is 
not annotated individually on the TL system, but rather recorded as an overall average 
insemination of all oocytes (Aguilar et al., 2014, Wirka et al., 2014). 
Studies focussing on differences in kinetic parameters between ICSI and IVF also 
show conflicting results. Time points delineating S-phase initiation between IVF and 
ICSI was shown to possibly differ in non-human models (Hewitson et al., 2000). Fishel 
et al. (2018) reported that IVF embryos had a longer tPNf of 1.95 hours post 
insemination compared to ICSI, which was one of their secondary findings. In contrast, 
Cruz et al. (2013), found that the kinetic time points do not differ between IVF and ICSI 
when a pre-determined, reference time point (t0) was used.  Ueda et al. (2012) 
reported that syngamy time for IVF was 21.2 ± 3.6 hours and was 20.8 ± 3.6 hours for 
ICSI, which was not significant. 
In this study, t0 was based on time of second polar body extrusion, which is the end 
of meiosis and oocyte activation, as well as the start of the new cell cycle for DNA 
replication and events preceding syngamy. Therefore, this study’s initial t0 time point 
allows an accurate and fixed annotation event from which genetic and fertilization 
events leading up to syngamy, can be investigated. This also minimizes time 
differences created prior to tPB2 by the method of insemination (IVF and ICSI) (Cruz 
et al., 2013). The current study’s calculation of syngamy timing is therefore the same 
as in the study by Ueda et al. (2012). Based on the fact that this study focussed on 
kinetic parameters to determine syngamy timing, it was decided that there was enough 
motivation to include both IVF and ICSI cycles. 
A total of 1811 normally fertilized oocyte records were included in the study. Syngamy 
timings included for statistical analysis were recorded in 1588 cases (zygotes). The 
dropout of 223 records could be because some annotations could not be assessed 
due to overnight IVF culture, as well as poor visualization preventing imaging of the 
second polar body extrusion and/or the pronuclear fading. The mean syngamy timing 
across all three male prognosis groups was 20.16 ± 4.13 hours.  
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This agrees with most mean syngamy timings reported in literature. In a study by Ueda 
et al. (2012), good quality embryos had a significantly shorter syngamy time of 20.0 ± 
3.3 hours, in comparison to poor quality embryos (22.10 ± 4.3 hours). They also 
showed that abnormally fertilized embryos had longer syngamy times of 25.10 ± 6.3 
hours, which showed a significant delay compared to normally fertilized embryos. In 
contrast, Azzarello et al. (2012) later reported that PN fading associated with live birth 
outcome (24.52 ± 0.35 hours) and earlier PN fading with no live birth (23.10 ± 0.23 
hours), but their calculation was from post insemination and not second polar body 
extrusion. Their main outcome measured was live birth rate, which is different from 
this current study’s outcome of blastocyst grading parameters, therefore it is difficult 
to directly compare syngamy timing results. 
One study included syngamy (Wirka et al. 2014). More studies reported on 
morphokinetic parameters and embryo quality on day 2 and 3, also without day 5 
(Lemmen et al., 2008, Wirka et al., 2014).  
Lemmen et al. (2008) used TL to identify markers after normal fertilization, which could 
be correlated to good quality embryos on day 2 and also implantation. Time-points 
included were PN fading after fertilization, nuclei appearance and disappearance in 
blastomeres and synchronization of cell cleavages. The results showed positive 
correlations between earlier PN disappearance after fertilization, earlier first cell 
cytokinesis and increased blastomere number on day 2 of embryo development. 
Positive correlations with pregnancy rate was found when nuclei appeared 
synchronously after first cell cytokinesis and good quality embryos were associated 
with synchronous development, but time range references were not reported.  
Wirka et al. (2014) reported that only 30% of the abnormal syngamy embryos resulted 
in good or fair quality embryos in comparison to the normal syngamy group where 
60% resulted in good or fair quality embryos. 
Several studies have reported on the influence of morphokinetic parameters on live 
birth and implantation (Meseguer et al., 2011, Azzarello et al., 2012). 
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Meseguer et al. (2011) reported a time duration of 4.04 hours from the time of PN 
fading until the time of first cell cleavage, which delineates the G2 and M phases. 
Results showed that the most predictive parameters of possible implantation were 
time of division to 5 blastomeres, time between division to 3 blastomeres and to 4 
blastomeres and duration of the two-cell cycle. Azzarello et al. (2012) investigated 
whether PN morphology and PN fading could predict live birth outcome. They found 
that embryos with PN fading earlier than 20.45 hours post insemination did not result 
in live birth.  
In the current study there was no overall statistical significance between the syngamy 
timings of the three male prognosis groups, although there was a noticeable trend 
showing that poorer male prognosis resulted in longer syngamy timings. Specifically, 
the VP group had 1.06 hours longer syngamy timing compared to the GP group, which 
was significant. Although not significant, the PP group had 0.47 hours longer syngamy 
timing compared to the GP group. Therefore, results in the current study suggest that 
male prognosis does affect the timing of syngamy. 
The effect of male prognosis on syngamy timing has not been studied extensively, but 
literature suggests that male factor infertility could play a role in embryo morphokinetic 
events (Wirka et al., 2014, Denomme et al., 2018).  
Denomme et al. (2018) reported that there was an increased miscarriage rate in OAT 
patients compared to normal male diagnosis patients. The methylation and 
transcriptome of OAT male factor patients resulted in aberrations which translate in 
epigenetic events that consequently lead to reduced reproductive potential of the 
embryo’s associated with poor male sperm (Denomme et al., 2018). The observed 
trend in our study of longer syngamy timing, increasing in poorer male prognosis 
groups, could be linked with study outcomes in literature.  
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The significant effect of female age on syngamy timing has been reported in 
literature. In a prospective, benchtop incubator study by (Lawler et al., 2007), it was 
shown that zygotes from females younger than 36 years entered syngamy earlier and 
had a better implantation potential when entering syngamy before 23 to 24 hours post 
insemination. Therefore, female age could have had a significant effect on syngamy 
timing, where younger patients (zygotes) could result in a significantly shorter 
syngamy timing. In the current study, female age was thus taken into account as a 
confounding factor and compensated for in statistical analysis of the study. 
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 Blastulation 
The overall blastulation rate of the three male prognosis groups in the current study 
was 66.76% and the post-hoc tests for blastulation rate between the three male 
prognosis groups showed no statistical significance. This indicates that in all three 
male prognosis groups the chance for reaching blastulation (tSB) was similar. 
The blastulation rate found in this study is in accordance with blastocyst 
developmental rates (competency rate of ≥ 40% and benchmark rate of ≥ 60%) 
reported in the Vienna consensus expert meeting (Apter et al., 2017). Regarding 
blastulation in the different male prognosis groups in the current study, the slightly 
higher (5-6%) non-significant blastulation rate results seen for the PP group, compared 
to the two others, is difficult to explain. A possible explanation could be because female 
factor infertility was less prevalent in the PP group compared to that in the VP and GP 
group. It is also possible that the increased blastulation rate seen in the PP group 
could be because ICSI compensated for poor semen parameters, especially sperm 
morphology. Therefore, adverse effects might be avoided when embryologists select 
the spermatozoa with the best morphology, which might not be representative of the 
entire sample (French et al., 2010). French et al. (2010) speculated that ICSI 
compensates for poorer quality samples by fertilizing oocytes with microscopically 
selected spermatozoa with the closest resemblance to normal morphology, which 
might make the pre-treatment morphology assessment irrelevant. This could also be 
true for the VP group, which had a blastulation rate similar to the GP group. However, 
this argument is challenged by other findings that state that IVF and ICSI show no 
significant difference in blastocyst rate (Westphal et al., 2003). 
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In this study, although there was a significant difference seen in the syngamy timing 
between the GP and VP group, there was no significant difference seen in blastulation 
rate. This could be because the spermatozoa contribute the centrosome during 
syngamy, which is a separate functional entity to the DNA. After syngamy and before 
blastulation, the embryo genome is activated, where the spermatozoa DNA quality 
plays a role. Literature has shown that male diagnosis groups, where spermatozoa 
were retrieved from the testis (VP), might have less DNA damage in comparison to 
ejaculated spermatozoa (GP) (Bungum et al., 2004, Weissman et al., 2008, 
Moskovtsev et al., 2010, Esteves et al., 2015). In addition to the fact of less DNA 
damage, ICSI also compensates for poor male prognosis and could therefore be the 
explanation to why these results were seen in this study. 
In the literature, there is contradictory evidence concerning blastulation rate in different 
male diagnosis groups. Some studies show no significant difference between male 
spermatozoa source or group, where others do. Desai et al. (2009) reported no 
difference in compaction or blastulation rates, respectively, amongst epididymal (74%, 
38%), obstructive azoospermic testicular (69%, 42%) or non-obstructive azoospermic 
testicular (79%, 38%) spermatozoa. French et al. (2010) also did not observe any 
difference in blastulation rate (41 to 50%) amongst different groups. Their results 
showed that fertilization, implantation, pregnancy and live birth rates were not 
statistically different between morphological spermatozoa groups and no effect was 
observed for blastocyst development or quality. Lammers et al. (2015) showed no 
significant difference in blastulation rates between ejaculated (52.52%) and surgically 
retrieved spermatozoa (59.07%). 
Other studies however, reported differences in blastulation rates from different 
spermatozoa sources or diagnosis groups (Mazzilli et al., 2017, Bartolacci et al., 
2018). Mazzilli et al. (2017) showed a significant difference in blastulation rate per 
fertilized oocyte in moderate male factor (48.6%) and non-obstructive azoospermia 
(40.6%) in comparison to normozoospermia (49.3%). Results by Bartolacci et al. 
(2018) showed a significant difference in blastulation rates, from the poorest male 
group (concentration < 1x106 per ml): 50.0 (33.3–66.3%) compared to the better male 
group (concentration ≥ 15x106 per ml): 55.6 (40.0–75.0%). However, they did not find 
a difference in development of top-quality blastocysts between the male groups. 
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Although in this current study the possible effect of syngamy timing on blastulation 
rate was not specifically investigated, it should be mentioned that there are studies 
suggesting a correlation. Wirka et al. (2014) showed significantly lower blastulation 
rates in embryos with atypical phenotypes (21.5%) i.e. abnormal syngamy, abnormal 
first cytokinesis, abnormal cleavage and chaotic cleavage in comparison to normal 
syngamy embryos (44.9%). 
Several studies have been performed on morphokinetic parameters to predict 
blastulation. One study included syngamy, and the effect on outcomes (Wong et al., 
2010, Desai et al., 2014, Milewski et al., 2015). 
Wong et al. (2010) identified three cleaving morphokinetic data parameters which 
could accurately predict blastocyst formation before day 4 of embryo development, 
using an algorithm they developed. The kinetic parameters included: first cell 
cytokinesis duration (t2-tPNf), time between the first mitosis completion and second 
mitosis initiation (t3-t2) and the time duration between the second and third mitoses 
(t4-t3).  
Milewski et al. (2015) also created a predictive model based on early cleaving 
morphokinetic parameters for blastocyst development on day 5. Parameters 
investigated included the first (t2), second (t3), third (t4) and fourth (t5) blastomere 
divisions, as well as the time duration between these divisions. The first (t2), fourth 
(t5) as well as time between the second (t3) third (t4) division was used as predictive 
timings for blastocyst formation. The study by Desai et al. (2014), reported on time to 
syngamy in poor quality and non-blastulating embryos (26.8 ± 8.3 hours) compared to 
blastocysts frozen (25.2 ± 3.0 hours). They also showed that tPNf, t2, t4, t8, s1, s2, s3 
and cc2 were significantly different in embryos forming blastocysts in comparison to 
embryos either failing to reach blastulation or forming poor quality blastocysts. 
Literature suggests that blastulation rate is also not influenced by insemination 
method, therefore supporting the inclusion of all insemination methods in this study. 
Westphal et al. (2003)  showed no difference between ICSI and IVF with regards to 
blastulation (78% in IVF and 73% in ICSI) or viable pregnancy rates (51.4% in IVF and 
55% in ICSI) in patients who had abnormal semen parameters or previously failed IVF 
cycles.  
Stellenbosch University  https://scholar.sun.ac.za
99 
 
Literature showed different findings on the effect that maternal age has on 
blastulation, with some studies showing earlier blastulation in younger patients than 
older patients, and other studies showing no influence of maternal age on blastulation 
rates (Sepúlveda et al., 2011, Hickman et al., 2013). In our study, female age did have 
a significant effect on the probability of blastulation, but was compensated for in all 
statistical analysis. 
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 Syngamy timing and blastocyst grading parameters 
In the current study, syngamy timing of an embryo showed a significant overall 
correlation with regards to the degree of blastocyst expansion. The post hoc analysis 
results revealed that there were specific significant differences in syngamy timing 
between day 5 blastocyst expansion grades. Shorter syngamy timings were 
significantly associated with advanced blastocyst development. Blastocyst expansion 
grades 1, 3, 4 and 5 had shorter syngamy timings compared to CM embryos. 
Blastocyst expansion grades 2, 3, and 5 had shorter syngamy timings compared to 
EB embryos. Expansion grades 4 and 5 had shorter syngamy timings compared to 
grade 1 of blastocyst expansion, grade 4 compared to grade 2 of blastocyst expansion, 
and grade 4 compared to grade 3 of blastocyst expansion. This result was the most 
significant and important outcome of the study. 
Studies that correlate blastocyst expansion and syngamy specifically are limited. Most 
studies only correlate blastocyst expansion with implantation and/or live birth. 
Blastocyst expansion has been shown in literature to be a very important predictive 
factor of LBR (Hill et al., 2013, Thompson et al., 2013, Desai et al., 2016, Du et al., 
2016).  
Hill et al. (2013) reported that implantation rates were significantly higher in expanded 
(64%) and hatched blastocysts (63%) compared to morula (38%) and early blastocysts 
(44%). Live birth rate was significantly decreased in morula (13%) compared to early 
blastocysts (37%), expanded blastocysts (53%) and hatched blastocysts (58%). They 
subsequently also reported that blastocyst stage development, including TE quality 
was significantly associated with implantation and live birth.  
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Thompson et al. (2013) found similar values for LBR outcomes associated with 
blastocyst stage, with expanded blastocysts (49.5%), hatching blastocysts (50%) and 
early blastocysts (36.7%). Results by Desai et al. (2016) showed that day 5 blastocyst 
expansion grades 3 and 4 was predictive of successful outcomes in comparison to 
day 6 blastocysts with the same expansion grade. Delayed blastocyst expansion, such 
as grades 1 and 2 in comparison to more expanded grades 3 and 4, negatively 
impacted implantation. Blastocyst expansion was therefore a strong predictor of 
outcomes such as implantation, clinical pregnancy and live birth rates. They also 
showed that univariate analysis of ICM and TE grading correlated positively with 
outcomes. 
Du et al. (2016) conducted a similar study to Desai et al. (2016), investigating the effect 
of all three parameters of blastocyst grading on live birth. Results also showed the 
degree of blastocoel expansion was predictive of live birth in fresh and vitrified-warmed 
single embryo transfer. Expansion degrees of 1 and 2 had lower birth rates in 
comparison to degrees 3 and 4. Neither ICM nor TE was correlated with live birth using 
logistic regression analysis.  
The syngamy timings of the three different male prognosis groups regarding 
blastocyst expansion showed no significant difference. This might indicate that the 
male prognosis played a lesser role in the degree of blastocyst expansion with regards 
to syngamy timing. Post hoc analysis also showed no significant difference between 
the syngamy timings for each expansion grade between the three male prognosis 
groups.  
This agreed with a study by Bartolacci et al. (2018) who investigated the effects of 
different spermatozoa diagnoses on overall embryo quality. They reported no 
significant difference in top quality blastocyst formation rate between men who had 
different degrees of oligozoospermia (<1 x 106 per ml, <5 x 106 per ml, and <15 x 106 
per ml) compared to the control group (≥15 x 106 per ml). However, this study did not 
investigate individual blastocyst grading parameters, but only overall grading. 
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In light of this study’s findings, which showed significant correlations of syngamy timing 
with degree of blastocyst expansion, irrespective of male prognosis, it could be argued 
that syngamy may be an important developmental event for expanding potential. 
Syngamy timing could therefore be a selection marker of advanced blastocyst 
expansion, which in turn, according to literature, is an important indicator of 
implantation potential. 
The overall syngamy timing of day 5 inner cell mass (ICM) grading showed no 
significant correlation. The post hoc analysis between the day 5 ICM gradings 
according to syngamy timings, also showed no statistical significance. Although the 
post hoc results showed no significant difference between syngamy timing of different 
ICM gradings, shorter syngamy timings were associated with better quality ICM grade 
(A-grade shorter than B-grade). The syngamy timings started to plateau between B- 
and C-grade ICM blastocysts. Female age as a possible confounding factor, showed 
no significant influence on the grade of ICM. 
The overall syngamy timing of all three male prognosis groups and the effect on 
day 5 inner cell mass (ICM) grading showed no significant correlation. Post hoc 
analysis also showed no statistically significant difference between male prognosis 
groups when correlation between day 5 ICM gradings and syngamy timings in each 
group were tested. However, there was an observable trend in the GP group, with 
poorer ICM grading associated with longer syngamy timing. The VP group showed a 
similar result, but the PP group showed an opposite trend, with a poorer ICM grading 
associated with shorter syngamy timing. The reason for this finding is difficult to 
explain and needs further investigation with larger sample sizes. This might underline 
the less important role of the ICM in blastocyst grading due to lower correlations with 
implantation potential.  
Recent studies in the literature investigated the role of the ICM and whether it has 
predictive value for outcomes such as live birth, however studies are contradictory. 
The findings of this study showed that ICM was neither influenced by syngamy timing, 
nor male prognosis group, which is similar to literature previously mentioned 
(Bartolacci et al., 2018) that reported no difference in top blastocyst formation rate 
between male diagnosis groups. 
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In the current study, syngamy timing compared to day 5 trophectoderm grade had 
no overall statistical significance, but was significant at the 90% confidence interval. 
The post hoc analysis revealed a statistical significance between the syngamy timings 
of A-grade and B-grade trophectoderm qualities. A grade trophectoderm had a 
significantly shorter syngamy timing compared to B grade trophectoderm. Syngamy 
timing between B- and C-gradings, as well as A- and C-gradings showed no significant 
differences. It is difficult to explain this non-significant result. Since the epithelial layer 
is not necessarily uniform and TE can be assessed on different focal planes, leading 
to possible uncertainty and inconsistent grading. These discrepancies could be more 
frequent between B- and C-gradings, which might be more difficult to differentiate, 
whereas A grade TE could be more discernible. However, the final grading is mostly 
corroborated by more than one embryologist. Therefore, a larger sample size could 
possibly clarify this unexpected result.  
The comparison of syngamy timings with day 5 trophectoderm grading across all three 
male prognosis groups was not statistically significant. However, the post hoc analysis 
showed a significantly shorter syngamy timing between an A-grade TE of the GP 
group and a B-grade TE of the VP group, as well as between the A- and B-grade 
trophectoderms in the VP group itself. Although not statistically significant, longer 
syngamy timing seemed to lead to poorer trophectoderm gradings in the GP and VP 
groups. The PP group did not follow a similar trend, with a consistent syngamy timing 
for all three trophectoderm gradings. The reason for this observation is difficult to 
explain. One possibility is due to the categorization of the PP group, which included 
borderline morphology diagnoses and oligozoospermia diagnosis (irrespective of 
morphology). Patients with a borderline morphology or low sperm count with increased 
normal morphology, possibly resulted in a better spermatozoa population for ICSI 
sperm selection.  
There are no published studies investigating syngamy timing of different male 
prognoses and its effect on day 5 blastocyst quality grading. However, the effect of 
semen parameters on other morphokinetic events and subsequent implantation and 
live birth rates have been evaluated, but also not on the quality of individual 
parameters of day 5 blastocysts (French et al., 2010, Lammers et al., 2015, Desai et 
al., 2018).  
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French et al. (2010) studied the effect of male sperm morphology on blastocyst quality 
and surprisingly observed a higher percentage of good quality blastocysts in the most 
severely teratozoospermic group with 0% normal forms in comparison to patients with 
≥5% normal forms (37% vs 28%). They attributed this outcome to a possible lower 
female factor infertility prevalence in this group. 
Lammers et al. (2015) compared the effect of fresh ejaculated and surgically (testicular 
and epididymal) retrieved spermatozoa in ICSI on embryo morphokinetic parameters. 
Clinical outcomes were measured and they showed that the outcomes were 
comparable between the groups of different sperm sources. Although, some early 
morphokinetic parameters between the groups had significant differences, time points 
included t3, t8 and s2. They concluded that there was no difference in morphokinetic 
analysis between fresh ejaculated and surgically retrieved sperm, but stated that more 
studies are required on the relationship between sperm origin and late morphokinetic 
parameters such as blastocyst development. 
Desai et al. (2018) also investigated kinetic embryo development and clinical 
outcomes in different spermatozoa sources, i.e. epididymal, testicular (obstructive and 
non-obstructive) and ejaculated normal spermatozoa. A lower compacting embryo 
rate in non-obstructive testicular spermatozoa compared to the others were seen, 
which is indicative of paternal activation (Desai et al., 2009). In the testicular sourced 
spermatozoa, significantly lower percentage of embryos showed kinetics typically 
attributed to high quality embryos. Results showed no difference in CPR between the 
groups and a non-significant decline in implantation and birth rate of testicular 
spermatozoa compared to epididymal spermatozoa and the control group. 
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The syngamy timing results in this current study, could predict TE quality between 
grade A and B. In conjunction with findings in the literature our results suggest that 
syngamy timing could possibly be an early predictor of TE quality and ART outcomes, 
such as implantation and live birth rates. Several studies have reported on blastocyst 
grading and pregnancy outcomes, not taking morphokinetic information into account. 
Some studies reported no correlation between ICM and live birth (Ahlström et al., 
2011, Hill et al., 2013, Ebner et al., 2016). Other studies showed that TE is predictive 
of implantation and other outcomes such as live birth (Ahlström et al., 2011, Hill et al., 
2013, Ebner et al., 2016) and some only showed correlation of TE when a univariate 
analysis was performed (Desai et al., 2016). 
The study by Ahlström et al. (2011) found that all three parameters (Expansion, TE 
and ICM) of blastocyst grading had an effect on live birth, but when confounding 
factors were adjusted for, only TE showed a strong correlation with live birth. The 
results of their GEE models showed a significant incremental increase in live birth rate 
from poor to better TE gradings: grade C (8.0%), compared to B (33.9%) and 
compared to A (49.9%). 
Hill et al. (2013) reported that implantation and live birth rates were higher in TE grades 
A (67%, 57%, respectively) compared to B (51%, 40%, respectively). Implantation 
rates were significantly lower in grade C (25%) compared to grade A TE, and live birth 
rates also lower in grade C TE, but was not statistically significant. However, they 
reported no significant difference in implantation or live birth rates between different 
ICM gradings A (63%, 53%, respectively), B (58%, 52%, respectively) or C (0%, 0%, 
respectively). 
Ebner et al. (2016) reported that quality and cell number of the TE outweighed ICM 
with regards to live birth outcome prediction, whereas other studies, as discussed 
above, reported a correlation between ICM and live birth in the case of a univariate 
analysis (Desai et al., 2016, Du et al., 2016). 
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Thompson et al. (2013) reported an association with TE morphology and LBR. LBR 
between the three TE scoring groups were 50% in the good scored group, 41.9% in 
the fair scored group and 30% in the poor scored group. No association was seen 
between LBR and ICM morphology. Thompson et al. (2013) reported on the combined 
outcome of blastocyst expansion and TE morphology in LBR. Results were better in 
the hatching blastocyst group (52% with good TE score, 51.1% with fair TE score, 
43.7% with poor TE score), in comparison to expanded blastocysts (46.5% with good 
TE score, 42.7% with fair TE score and 25.9% with poor TE score), with LBR being 
the lowest in the early blastocyst group (31.4% with good TE score, 32.9% with fair 
TE score and 38.7% with poor TE score).  
Syngamy timing and individual day 5 blastocyst quality grading parameters have not 
been studied or extensively reported in literature, although the relationship between 
morphokinetic time points, embryo quality, blastulation and ART outcomes have been 
investigated. 
The study by Desai et al. (2014) reported on time to syngamy in blastocysts transferred 
(24.8 ± 2.6 hours), in blastocysts implanting (24.1 ± 2.5 hours), compared to 
blastocysts not implanting (26.2 ± 2.7 hours). 
The results of this study, in conjunction with findings reported in the literature, suggest 
that syngamy timing may be a relevant early morphokinetic time point correlating with 
blastulation, especially blastocyst expansion and to some extent with trophectoderm 
morphology, irrespective of male factor prognosis. 
Combined results on blastocyst expansion and TE morphology of our study is 
therefore strongly suggested to have an even further impact on other outcomes such 
as LBR. Therefore, our findings might be of significant value for future embryo 
selection for transfer and ART outcomes. 
Since literature has shown that both our main findings, blastocyst expansion and 
trophectoderm, are strong predictive markers of ART outcomes, syngamy timing could 
be an early indicator of blastocyst expansion and trophectoderm quality, therefore also 
possibly predicting implantation and other associated ART outcomes. 
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CHAPTER 5  
CONCLUSION 
A limited number of studies correlating syngamy timing and individual blastocyst 
grading parameters, as well as the effect of male factor prognosis have been 
published. In our study, we aimed to elucidate the effect of male prognosis on syngamy 
timing and subsequent blastulation.  
Our results showed that syngamy timing correlated significantly to blastocyst 
expansion overall, with shorter syngamy timing resulting in greater expansion. No 
statistical significance between the mean syngamy timings of the three male prognosis 
groups were found. However, it seemed that mean syngamy timing increased with 
poorer male prognosis. No statistical significance with ICM grading overall or between 
male prognosis groups were seen; although an A-grade ICM seemed to have a shorter 
mean syngamy timing. No statistical significance with trophectoderm grading overall 
or between male prognosis groups were found. Although, an A-grade trophectoderm 
showed a significantly shorter syngamy timing in comparison to B-grade 
trophectoderm. 
The inherent process of syngamy and effect on the final embryo genome product 
thereof could therefore have an effect on blastulation formation and blastocyst grading 
outcome. Blastocyst expansion and TE quality, the two most important grading 
parameters for embryo selection and transfer, was associated with syngamy timing in 
this study and with improved ART outcomes in the literature. 
ICSI used in conjunction with sperm selection, could compensate for poor male 
prognosis, and although not statistically significant, a definite observable trend was 
seen in the study - showing a longer syngamy timing in the poorer male prognosis 
groups. The centrosome and inherent spermatozoa quality, a final contributor to the 
syngamy process, could possibly have an effect on ART outcomes.  
Since only blastocyst quality correlated with syngamy timing, irrespective of male 
prognosis group, this finding could be explained by the inherent spermatozoon DNA 
quality that only affects syngamy and not blastocyst quality grading. 
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Based on literature and in conjunction with the findings of this study, we suggest that 
the grade of blastocyst expansion and trophectoderm epithelium quality between A 
and B could be predicted as early as syngamy timing. Syngamy timing could therefore 
be applied either as a single or additional parameter in embryo selection methods to 
increase the probability of implantation and live birth. 
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CHAPTER 6  
FUTURE PROSPECTS 
Due to the limited literature on syngamy, its calculation inconsistency and lack of 
association with sperm quality, blastulation and ART outcomes, further research is 
needed. 
Suggestions for the future research and improvement of the current study should take 
the limitations of the study into consideration. 
The female population of the study was heterogenous, therefore maternal influences 
such as female diagnosis was not considered in the study analysis. Female oocyte 
quality might also play a role in syngamy and EGA. Abnormal oocyte DNA and 
cytoplasm contents might also be a contributing factor to aneuploid embryos or 
abnormal syngamy. These factors could be eliminated to some extend in future studies 
by including a homogenous female population of only donor oocytes or by categorizing 
oocytes into groups according to female diagnosis (PCOS, endometriosis, 
anovulation, poor responders, recurrent pregnancy loss).  
DNA fragmentation tests, such as TUNEL, could be included in addition to semen 
analysis diagnosis to ensure better defined male prognosis groups. However, it will be 
challenging to perform TUNEL assays on severe oligozoospermia and testicular 
retrieved spermatozoa samples.  
In order to determine whether the observed trends and results that showed 
significance at the 90% confidence intervals could reach statistical significance at the 
95% confidence interval, two aspects of this study can be addressed. Stricter 
categorization of male prognosis groups would possibly optimize diagnosis 
separations and could improve delineation of differences between groups. Larger 
sample sizes might also elucidate whether true differences exist by increasing the 
statistical significance. 
The predictive value of syngamy timing for blastocyst expansion and trophectoderm 
epithelium should be validated and confirmed through prospective studies, as this 
study only analysed this retrospectively. 
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A multicentred study would evaluate the applicability of syngamy timing as an 
important early morphokinetic predictive marker for broader laboratory settings. 
The outcomes measured in this study could be extended to include implantation, 
clinical pregnancy and live birth rates. It would be interesting and of additional value 
to compare pregnancy outcomes with published results readily available in the 
literature. 
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APPENDICES 
 Appendix A: Definition lists 
General definitions 
Allele “One of two or more alternate forms of a gene” (Pierce, 
2012). 
 
Blastocyst An embryo, 5 or 6 days after fertilization, with an inner cell 
mass, outer layer of trophectoderm, and a fluid-filled 
blastocoel cavity. 
 
Blastulation rate The number of blastocysts formed from normally fertilized 
zygotes. 
 
Centriole “Cytoplasmic organelle consisting of microtubules; present 
at each pole of the spindle apparatus in animal cells” 
(Pierce, 2012). 
 
Centrosome “Structure form which the spindle apparatus develops: 
contains the centriole” (Pierce, 2012). 
 
Chromosome “Structure consisting of DNA and associated proteins that 
carries and transmits genetic information” (Pierce, 2012). 
 
Crossing over  “Exchange of genetic material between homologous but 
non-sister chromatids” (Pierce, 2012). 
 
Embryo quality Grading of an embryo based on morphological 
characteristics, to estimate implantation potential of embryo 
and serve as a method of embryo selection. 
 
Fertilization The penetration of the ovum by the spermatozoon and 
fusion of genetic materials resulting in the development of a 
zygote. 
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Implantation rate “The number of gestational sacs observed divided by the 
number of embryos transferred” (Zegers and Adamson, 
2009). 
 
Intracytoplasmic 
sperm injection 
(ICSI) 
A procedure in which a single motile spermatozoon is 
injected into the oocyte cytoplasm. 
 
Morphokinetic 
events 
All embryo parameters or main developmental milestones 
which occur from fertilization to blastulation. 
 
Syngamy The fusion of the nuclei from the maternal and paternal 
gametes. 
Zygote A diploid cell resulting from the fertilization of an oocyte by 
a spermatozoon, which subsequently divides to form an 
embryo. 
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Female diagnosis definition list 
Anovulation “Anovulation is the failure of the ovary to release ova over a 
period of time generally exceeding 3 months” (Davis and 
Segars, 2009) 
 
Donor Oocytes “An ART cycle in which oocytes are collected from an egg 
donor for reproductive purposes or research” (Zegers-
Hochschild et al., 2017).  
 
Endometriosis “A disease characterized by the presence of endometrium-
like epithelium and stroma outside the endometrium and 
myometrium. Intrapelvic endometriosis can be located 
superficially on the peritoneum (peritoneal endometriosis), 
can extend 5 mm or more beneath the peritoneum (deep 
endometriosis) or can be present as an ovarian 
endometriotic cyst (endometrioma)” (Zegers-Hochschild et 
al., 2017).  
 
Ideopathic “Infertility in couples with apparently normal ovarian 
function, Fallopian tubes, uterus, cervix and pelvis and with 
adequate coital frequency; and apparently normal testicular 
function, genito-urinary anatomy and a normal ejaculate. 
The potential for this diagnosis is dependent upon the 
methodologies used and/or those methodologies available” 
(Zegers-Hochschild et al., 2017).  
 
Advanced Maternal 
Age 
“Patients 39 years of age and older” (SARA, 2014). 
 
 
Recurrent 
Miscarriage 
“The spontaneous loss of two or more clinical pregnancies 
prior to 22 completed weeks of gestational age” (Zegers-
Hochschild et al., 2017).  
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Oligomenorrhea “Fewer than 9 periods per year (cycle length > 38–40 
days)” (Rosenfield, 2013). 
 
Polycystic Ovarian 
Syndrome 
“A heterogeneous condition, which requires the presence of 
two of the following three criteria: (1) Oligo-ovulation or 
anovulation; (2) Hyperandrogenism (clinical evidence of 
hirsutism, acne, alopecia and/or biochemical 
hyperandrogenemia); (3) Polycystic ovaries, as assessed by 
ultrasound scan with more than 24 total antral follicles (2–9 
mm in size) in both ovaries” (Zegers-Hochschild et al., 
2017).  
 
Polycystic Ovaries “An ovary with at least 12 follicles measuring 2–9 mm in 
diameter in at least one ovary (Rotterdam criteria). PCO 
may be present in women with PCOS, but also in women 
with normal ovulatory function and normal fertility” (Zegers-
Hochschild et al., 2017). 
 
Poor Ovarian 
Reserve 
“A term generally used to indicate a reduced number and/or 
reduced quality of oocytes, such that the ability to reproduce 
is decreased” (Zegers-Hochschild et al., 2017).  
 
Poor Ovarian 
Response (POR)  
“A condition in which fewer than four follicles and/or oocytes 
are developed/obtained following ovarian stimulation with 
the intention of obtaining more follicles and oocytes” 
(Zegers-Hochschild et al., 2017).  
 
Premature Ovarian 
Failure 
“A condition characterized by hypergonadotropic 
hypogonadism in women younger than age 40 years (also 
known as premature or primary ovarian failure). It includes 
women with premature menopause” (Zegers-Hochschild et 
al., 2017).  
 
Same sex-couples / 
Single Female 
Female couples / single couples who require donor sperm 
in order to undergo ART. 
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Tubal Factor “Tubal abnormality resulting in dysfunction of the Fallopian 
tube, including partial or total obstruction of one or both 
tubes (proximally, distally or combined), hydrosalpinx and/or 
peri-tubal and/or peri-ovarian adhesions affecting the 
normal ovum pick-up function. It usually occurs after pelvic 
inflammatory disease or pelvic surgery” (Zegers-Hochschild 
et al., 2017). 
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Male diagnosis definition list  
Azoospermia “The absence of spermatozoa in the ejaculate” (Zegers 
and Adamson, 2009, WHO, 2010).  
 
Asthenozoospermia Poor motility and/or forward progression (< 30% motility 
and/or < 2 forward progression). 
 
Donor sperm “The process of placing laboratory processed sperm or 
semen from a man into the reproductive tract of a woman 
who is not his intimate sexual partner, for the purpose of 
initiating a pregnancy” (Zegers-Hochschild et al., 2017).  
 
Normozoospermia “All semen parameters are normal (equal to or above the 
lower reference limits)“ (WHO, 2010). 
 
Non-obstructive 
Azoospermia 
“Absence of spermatozoa in the ejaculate due to lack of 
production of mature spermatozoa” (Zegers-Hochschild 
et al., 2017). 
 
Obstructive 
Azoospermia 
“Absence of spermatozoa in the ejaculate due to 
occlusion of the ductal system” (Zegers-Hochschild et al., 
2017). 
 
Oligozoospermia “Low concentration of spermatozoa in the ejaculate below 
15 x 106 per ml” (Zegers and Adamson, 2009). 
 
Teratozoospermia “Reduced percentage of morphological normal 
spermatozoa (≤ 4%)” (Zegers and Adamson, 2009). 
 
Testicular Biopsy “A surgical procedure involving one or more testicular 
biopsies or needle aspirations to obtain sperm for use in 
IVF and/or ICSI” (Zegers and Adamson, 2009).  
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Vasectomy “Procedure to occlude the vas deferens. It is usually 
carried out bilaterally in order to secure sterilization” 
(Zegers and Adamson, 2009).  
 
Vasovasostomy Surgical reversal of a vasectomy. 
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 Appendix B: Wijnland Fertility Andrology reference values. 
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 Appendix C: Example of data spreadsheet 
 
Embryo 
ID 
 
Prognosis  
Group 
Female 
Diagnosis 
Male  
Diagnosis 
Female  
Age 
PN_Val tPB2 tPNa tPNf t2 tSB 
Morphological 
 Grade 
0123_1 GP Endometriosis Normozoospermia 34.5 2 4.81 5.81 21.6 24 88.2 3AA 
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 Appendix D: Two-way table of female diagnoses 
 
Primary Female Diagnosis Primary Female Diagnosis Primary Female Diagnosis Primary Female Diagnosis Primary Female Diagnosis Primary Female Diagnosis Primary Female Diagnosis Primary Female Diagnosis Primary Female Diagnosis Primary Female Diagnosis Primary Female Diagnosis Primary Female Diagnosis Row
Advanced Mat age Unexplained Donor egg PCO Tubal factor Endometriosis Premature Ovarian Failure Oligomenorrhea Anovulation POR Recurrent Miscarriage Single Female Totals
GP 91 162 145 30 64 14 6 3 6 10 6 0 537
Row % 16.95% 30.17% 27.00% 5.59% 11.92% 2.61% 1.12% 0.56% 1.12% 1.86% 1.12% 0.00%
PP 182 349 55 78 18 13 18 0 9 16 2 6 746
Row % 24.40% 46.78% 7.37% 10.46% 2.41% 1.74% 2.41% 0.00% 1.21% 2.14% 0.27% 0.80%
VP 59 149 42 7 3 2 1 0 0 25 17 0 305
Row % 19.34% 48.85% 13.77% 2.30% 0.98% 0.66% 0.33% 0.00% 0.00% 8.20% 5.57% 0.00%
Totals 332 660 242 115 85 29 25 3 15 51 25 6 1588
Group
Marked cells have counts > 10. Chi-square(df=22)=292.08, p=0.0000 Fisher Exact(r x c) p=p<0.01
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 Appendix E: LSD test table of syngamy timing and blastocyst expansion 
1st 2nd Mean Standard p
Mean Mean Differ. Error
{1}-{2} 1 2 0,68 0,4 0,08
{1}-{3} 1 3 0,62 0,36 0,08
{1}-{4} 1 4 1,41 0,36 0
{1}-{5} 1 5 1,04 0,53 0,05
{1}-{6} 1 VB -0,22 0,38 0,57
{1}-{7} 1 KM -1,17 0,52 0,02
{2}-{3} 2 3 -0,06 0,31 0,84
{2}-{4} 2 4 0,73 0,32 0,02
{2}-{5} 2 5 0,35 0,5 0,48
{2}-{6} 2 VB -0,9 0,35 0,01
{2}-{7} 2 KM -1,86 0,49 0
{3}-{4} 3 4 0,79 0,25 0
{3}-{5} 3 5 0,42 0,46 0,37
{3}-{6} 3 VB -0,84 0,29 0
{3}-{7} 3 KM -1,79 0,45 0
{4}-{5} 4 5 -0,38 0,46 0,41
{4}-{6} 4 VB -1,63 0,29 0
{4}-{7} 4 KM -2,59 0,46 0
{5}-{6} 5 VB -1,25 0,48 0,01
{5}-{7} 5 KM -2,21 0,6 0
{6}-{7} VB KM -0,95 0,46 0,04
Comparisons Cell {#1}-{#2}
LSD test; variable Syngamy Time (Spreadsheet in Cheyenne Steyn - MSc Prof Kidd datastel Feb 2018.stw) Simultaneous confidence intervals Effect: Grade Exp D5(116-125H)
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 Appendix F: Health Research Ethics Committee Approval Letter 
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 Appendix G: ART Procedures - Wijnland Fertility Clinic SOP’s 
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